RAMSAY MANAGED CARE INC, 10QSB, 1996-11-19

RAMSAY MANAGED CARE INC
10QSB, 1996-11-19
HEALTH SERVICES

Previous: KNICKERBOCKER L L CO INC, 10QSB, 1996-11-19

Next: ADVANCED VOICE TECHNOLOGIES INC, 10QSB, 1996-11-19

<PAGE>

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-QSB

(MARK ONE)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1996

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the Transition period from ____________________to__________________

Commission file No. 0-26666

RAMSAY MANAGED CARE, INC.

(Exact name of small business issuer as specified in its charter)

DELAWARE 72-1249464
(STATE OR OTHER JURISDICTION (I.R.S. EMPLOYER OF
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)

ONE POYDRAS PLAZA
639 LOYOLA AVENUE, SUITE 1725
NEW ORLEANS, LOUISIANA 70113
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)

Issuer's telephone number, including area code: (504) 585-0515

Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15 (d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.

Yes X No ___
---

The number of shares of the Registrant's Common Stock outstanding at November 2,
1996 follows:

Common Stock, par value $0.01 per share - 6,397,304 shares

Transitional Small Business Disclosure Format (Check one): Yes ___ No X
----

------------------
<PAGE>

RAMSAY MANAGED CARE, INC.

FORM 10-QSB

INDEX

Page
----
Part I. FINANCIAL INFORMATION

Item 1. Financial Statements
<S> <C>
Consolidated balance sheets - September 30, 1996
and June 30, 1996 (unaudited)........................................... 1

Consolidated statements of operations - quarters ended September 30, 1996
and 1995 (unaudited).................................................... 3

Consolidated statements of cash flows - quarters ended September 30,
1996 and 1995 (unaudited)............................................... 4

Notes to consolidated financial statements -
September 30, 1996 (unaudited).......................................... 5

Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations.............................. 10

Part II. OTHER INFORMATION

Item 5. Other Information.................................................. 16

Item 6. Exhibits and Current Reports on Form 8-K........................... 17

SIGNATURES................................................................. 18

</TABLE>
<PAGE>

PART I. FINANCIAL INFORMATION

RAMSAY MANAGED CARE, INC.

CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
<TABLE>
<CAPTION>

SEPTEMBER 30 JUNE 30
1996 1996
------------ -----------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents....................... $ 156,000 $ 228,000
Accounts receivable, less allowance for doubtful
accounts of $291,000 and $334,000 at September
30 and June 30, 1996 respectively.............. 1,168,000 846,000
Prepaid expenses................................ 339,000 382,000
Other current assets............................ 28,000 37,000
Current assets of discontinued operation........ 1,065,000 1,744,000
----------- -----------
Total current assets............................. 2,756,000 3,237,000

Other assets:
Goodwill and other intangible assets............ 8,160,000 8,152,000
Other non-current assets........................ 60,000 60,000
Other assets of discontinued operation.......... 2,154,000 1,862 ,000
----------- -----------
Total other assets............................... 10,374,000 10,074,000

Property and equipment:
Building and improvements....................... 128,000 128,000
Equipment, furniture and fixtures............... 1,880,000 1,830,000
----------- -----------
2,008,000 1,958,000
Less accumulated depreciation................... 1,234,000 1,170,000
----------- -----------
Total property and equipment..................... 774,000 788,000
--------------------------
Total assets..................................... $13,904,000 $14,099,000
=========== ===========

</TABLE>

See accompanying notes.

1
<PAGE>

RAMSAY MANAGED CARE, INC.

CONSOLIDATED BALANCE SHEETS (CONTINUED)
(UNAUDITED)
<TABLE>
<CAPTION>

SEPTEMBER 30 JUNE 30
1996 1996
------------- -------------

<S> <C> <C>
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable................................ $ 1,224,000 $ 1,397,000
Accrued salaries and wages...................... 797,000 641,000
Hospital and medical claims payable............. 1,857,000 1,667,000
Other current liabilities....................... 520,000 959,000
Line of credit and note payable................. 1,500,000 1,900,000
Current portion of long-term debt............... 2,604,000 2,334,000
Current liabilities of discontinued operation... 1,604,000 1,579,000
Reserve for operating loss from
discontinued operation......................... 992,000 1,830,000
------------ ------------
Total current liabilities........................ 11,098,000 12,307,000

Due to affiliate................................. 2,524,000 1,851,000
Advance from affiliate........................... -- 1,600,000
Deferred income taxes............................ 1,014,000 986,000
Long-term debt, less current portion............. 4,707,000 5,202,000

Stockholders' equity:
Convertible preferred stock, $.01 par value
- authorized 1,000,000 shares; issued 100,000
shares at September 30, 1996 and -0- shares
at June 30, 1996............................... 3,000,000 --
Common stock, $.01 par value - authorized
20,000,000 shares; issued 6,397,304 shares at
September 30, 1996 and 6,397,304 shares at
June 30, 1996................................... 64,000 64,000
Additional paid-in capital....................... 7,095,000 7,095,000
Accumulated deficit.............................. (15,598,000) (15,006,000)
------------ ------------
Total stockholders' deficit...................... (5,439,000) (7,847,000)
------------ ------------
Total liabilities and stockholders' equity....... $ 13,904,000 $ 14,099,000
============ ============

</TABLE>

See accompanying notes.

2
<PAGE>

RAMSAY MANAGED CARE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
<TABLE>
<CAPTION>

QUARTER ENDED
SEPTEMBER 30 SEPTEMBER 30
1996 1995 (a)
------------- --------------
<S> <C> <C>
Revenues:
Managed care revenue................................ $5,181,000 $ 4,289,000
Clinical fee for service and other revenue.......... 641,000 429,000
---------- -----------
Total revenues....................................... 5,822,000 4,718,000

Operating expenses:
Contracted provider services........................ 2,423,000 1,653,000
Salaries, wages and benefits........................ 2,189,000 2,184,000
Management fees charged by related companies........ 88,000 70,000
General and administrative expenses................. 1,121,000 1,165,000
Depreciation and amortization....................... 355,000 297,000
Interest and other financing charges................ 238,000 183,000
---------- -----------
Total operating expenses............................. 6,414,000 5,552,000
---------- -----------

Loss from continuing operations before income taxes.. (592,000) (834,000)
Income tax expense................................... -- --
---------- -----------
Loss from continuing operations...................... (592,000) (834,000)
Discontinued operation:
Loss from operations of discontinued HMO operation.. -- (338,000)
---------- -----------

Net loss............................................. $ (592,000) $(1,172,000)
========== ===========

Loss per common share from continuing operations..... $ (0.09) $ (0.13)
Loss per common share from discontinued operation.... 0.00 (0.05)
---------- -----------
Loss per common share................................ $ (0.09) $ (0.18)
========== ===========

Weighted average number of shares outstanding........ 6,397,304 6,370,909
========== ===========

</TABLE>
(a) Certain amounts for the quarter ended September 30, 1995 have been
reclassified to reflect the Company's discontinued HMO operation.

See accompanying notes.

3
<PAGE>

RAMSAY MANAGED CARE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
<TABLE>
<CAPTION>
QUARTER ENDED
SEPTEMBER 30 SEPTEMBER 30
1996 1995 (a)
------------- -------------

<S> <C> <C>
CASH FLOWS FROM CONTINUING OPERATING ACTIVITIES
Net loss from continuing operations............................. $(592,000) $(834,000)
Adjustments to reconcile net loss from continuing operations
to net cash (used in) provided by operating activities:
Depreciation and amortization................................. 355,000 297,000
Other......................................................... 27,000 --
Cash flows from (increase) decrease in operating assets:
Accounts receivable, net................................... (322,000) 168,000
Prepaid expenses........................................... 43,000 (304,000)
Other current assets....................................... 9,000 503,000
Cash flow from increase (decrease) in operating liabilities:
Accounts payable........................................... (173,000) (758,000)
Accrued salaries, wages and other liabilities.............. 156,000 211,000
Hospital and medical claims payable........................ 190,000 (74,000)
Due to affiliate........................................... 673,000 76,000
Other current liabilities.................................. (439,000) (101,000)
--------- ---------
Total adjustments............................................... 519,000 18,000
--------- ---------
Net cash (used) provided by operating activities................ (73,000) (816,000)
--------- ---------

CASH FLOWS FROM DISCONTINUED OPERATION
Net loss from discontinued operation............................ -- (338,000)
Adjustments to reconcile net loss from discontinued operation
to net cash used in discontinued operation:
Depreciation and amortization................................. -- 33,000
(Increase) decrease in current assets of
discontinued operation...................................... 679,000 129,000
(Increase) decrease in other assets of
discontinued operation...................................... (292,000) (438,000)
Increase (decrease) in current liabilities of
discontinued operation...................................... 25,000 63,000
(Decrease) in reserve for operating loss from
discontinued operation...................................... (838,000) --
--------- ---------
Total adjustments............................................... (426,000) (213,000)
--------- ---------
Net cash used in discontinued operation......................... (426,000) (551,000)
--------- ---------

</TABLE>

See accompanying notes.

4
<PAGE>

RAMSAY MANAGED CARE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(UNAUDITED)
<TABLE>
<CAPTION>
QUARTER ENDED
SEPTEMBER 30 SEPTEMBER 30
1996 1995 (a)
------------- -------------
<S> <C> <C>
CASH FLOWS FROM INVESTING ACTIVITIES
Expenditure for property and equipment................. (50,000) (109,000)
Goodwill, preopening and development costs............. (298,000) (144,000)
Other non-current assets............................... -- 77,000
----------- -----------
Net cash used in investing activities.................. (348,000) (176,000)
----------- -----------

CASH FLOWS FROM FINANCING ACTIVITIES
Advances from (payments to) affiliate.................. (1,600,000) --
Incurrance of (payment on) debt........................ (625,000) 102,000
Repayment on note receivable to purchase common stock.. -- 10,000
Issuance of preferred stock............................ 3,000,000 --
----------- -----------
Net cash (used) provided by financing activities....... 775,000 112,000
----------- -----------
Net (decrease) increase in cash and cash equivalents... (72,000) (1,431,000)
Cash and cash equivalents at beginning of period....... 228,000 3,495,000
----------- -----------
Cash and cash equivalents at end of period............. $ 156,000 $ 2,064,000
=========== ===========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid (received) during the period for:
Interest.............................................. $ 107,000 $ 179,000
=========== ===========
Income taxes.......................................... $ (95,000) $ (158,000)
=========== ===========

</TABLE>
(a) Certain amounts for the quarter ended September 30, 1995 have been
reclassified to reflect the Company's discontinued HMO operation.

See accompanying notes.

5
<PAGE>

RAMSAY MANAGED CARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
SEPTEMBER 30, 1996

NOTE 1.

The accompanying unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for
interim financial information and with the instructions to Form 10-QSB and
Article 10 of Regulation S-B. Accordingly, they do not include all of the
information and notes required by generally accepted accounting principles
for complete financial statements. In the opinion of management, all
adjustments considered necessary for a fair presentation of the interim
information are of a normal recurring nature and have been included. The
Company's business is seasonal in nature and subject to general economic
conditions and other factors. Accordingly, operating results for the
quarter ended September 30, 1996 are not necessarily indicative of the
results that may be expected for the year. For further information, refer
to the consolidated financial statements and notes thereto included in the
Company's Annual Report on Form 10-KSB for the year ended June 30, 1996

The Company was incorporated in the State of Delaware in July 1993, and
commenced operations with the acquisition of Florida Psychiatric
Management, Inc. ("FPM") on October 31, 1993.

Certain amounts for the quarter ended September 30, 1995 have been
reclassified to reflect the Company's discontinued HMO operation.

NOTE 2.

As of October 30, 1996, the Company entered into a definitive agreement
to sell its HMO operation to an established healthcare provider (see "Item
5. - Other Information" below).

The closing of the sale is subject to regulatory approvals, third party
consents and other customary closing conditions.

Due to these conditions, the Company will not adjust the loss on sale of
discontinued operation ($4,927,000) that was recorded for the year ended
June 30, 1996 until the completion of the sale.

NOTE 3.

As previously announced, on October 1, 1996, the Company and Ramsay
Health Care, Inc. ("RHCI") entered into an Agreement and Plan of Merger
providing for the merger of the Company into a wholly owned subsidiary of
RHCI. Following the merger, all amounts owed to RHCI by the Company will
become an intercompany payable and receivable between the Company and RHCI,
respectively.

6
<PAGE>

The merger is subject to approval by the shareholders of each company,
the receipt of lender, governmental and other consents and the declaration
of effectiveness by the Securities and Exchange Commission of a
registration statement filed by RHCI. Subject to the satisfaction of these
conditions, it is expected that the merger will be consummated in March
1997.

NOTE 4.

The Company's long-term debt consists of the following:

SEPTEMBER 30 JUNE 30
1996 1996
------------ -----------
<S> <C> <C>
8% 6-year unsecured promissory note issued
to Ramsay Health Care, Inc. payable
quarterly, due September 30, 2000................... $6,000,000 $6,000,000
Variable rate (interest rate of 8.1601% at September
30, 1996), 3-year secured term loan to First
Union National Bank of Florida, Inc.,
payable quarterly, due January 31, 1998............. 972,000 1,111,000
8.25% 3-year secured promissory note issued in
connection with the acquisition of HDI,
payable monthly, due June 30, 1997.................. 250,000 333,000
3-year secured term loan to First Union
National Bank of Florida, Inc., payable
monthly through April 5, 1999, interest at
prime plus 1% (interest of 9.25% at September
30, 1996)............................................ 89,000 92,000
---------- ----------
7,311,000 7,536,000
Less amounts due within one year...................... 2,604,000 2,334,000
---------- ----------
$4,707,000 $5,202,000
========== ==========

</TABLE>

The 8%, six-year, unsecured promissory note (the "Subordinated Promissory
Note") issued to RHCI, which is the Company's former parent corporation,
represents certain amounts due to RHCI at October 25, 1994. The note is
subordinated and junior to all indebtedness of the Company. See note 3
above and "Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations - Indebtedness" below.

On April 26, 1996, the Company amended its credit facility (the "Credit
Facility") with the First Union National Bank of Florida (the "Bank"). A
previous Revolving Credit Facility for up to $4,200,000 was replaced by a
$1,500,000 Revolving Master Line of Credit (the "Master Revolver") and a
$100,000 Term Loan.

The Master Revolver will expire on December 31, 1996 and the Term Loan is
repayable in 36 level monthly principal payments of $2,777.70, plus
interest. At September 30, 1996, $1,500,000 was outstanding under the
Master Revolver. The Master Revolver bears interest at the following
rates, as applicable and selected by the Company from time to time: (i) the
Bank's LIBOR adjusted rate plus 3.0% or (ii) the Bank's prime rate plus
0.75%. The $100,000 Term Loan bears interest at the Bank's prime rate plus
1.0%.

7
<PAGE>

As part of the acquisition of FPM in October 1993, the Company issued 7%
three year debentures, totaling $2,500,000. These debentures were prepaid
with the proceeds of a $1,667,000 three year secured term loan from the
Bank on April 28, 1995. This three year term loan bears interest at (i) the
Bank's LIBOR adjusted rate plus 2.5% or (ii) the Bank's prime rate plus
0.50%, as selected by the Company. Principal on this three year term loan
is payable quarterly with a final maturity of January 31, 1998. This three
year secured term loan, the additional Term Loan of $100,000 (referred to
above) and the Master Revolver are secured by a pledge of the stock RMCI's
subsidiaries and the assets of RMCI's subsidiaries, and are required to be
repaid with a portion of the proceeds from the sale of the Company's HMO
operation (see Note 2 above and "Item 5. - Other Information" below).

The Credit Facility contains covenants customary for facilities of this
type, which include, without limitation, covenants which contain
limitations on the ability of FPM and its subsidiaries, subject to certain
exceptions, to (i) assume or incur liens, (ii) alter the nature of their
business or effect mergers, consolidations, or sales of assets, (iii) incur
indebtedness or make investments, (iv) acquire businesses, or (v) pay
dividends to the Company. In addition, the Credit Facility contains
financial covenants related to senior debt to cash flow, interest coverage,
and minimum stockholders' equity. At June 30, 1996, FPM's minimum
stockholders' equity ratio was less than the requirement. The Bank agreed
to waive this requirement for the year ended June 30, 1996.

In connection with the Company's acquisition of certain assets of Human
Dynamics Institute ("HDI"), through a wholly owned subsidiary, FPMBH of
Arizona, Inc., the Company issued a promissory note in the principal amount
of $1,000,000 (the "HDI Note") to Phoenix South Community Mental Health
Centers ("Phoenix South"). Interest accrues on the HDI Note at a fixed
rate of 8.25% per annum and payable monthly in arrears, together with equal
installments of principal, until the HDI Note matures on June 30, 1997.
The HDI Note is secured pursuant to a Stock Pledge Agreement dated June 30,
1994, pursuant to which Phoenix South has a first priority lien on all of
the common stock of FPMBH of Arizona, Inc. Upon payment in full of the HDI
Note, the Bank will have a first priority lien on the common stock of FPMBH
of Arizona under the Credit Facility.

As at June 30, 1996, the aggregate amount of principal on the Company's
indebtedness payable during the fiscal year of the Company ending June 30,
1997 and during each of the four next four fiscal years of the Company will
be approximately $2,334,000, $2,001,000, $1,437,000, $1,412,000, and
$352,000, respectively.

NOTE 5.

The provision for income taxes included in the consolidated
statements of operations differs from the amounts computed by applying the
normal statutory rates to income before income taxes because such provision
includes (a) amounts reportable as income for federal income tax purposes
which are not income for financial reporting purposes, (b) amounts deducted
for financial reporting purposes that are not allowable deductions for
Federal and state income tax purposes and (c) amounts for state income

8
<PAGE>

taxes applicable to profitable subsidiaries which do not utilize the
operating losses generated by unprofitable subsidiaries to offset taxable
income. At September 30, 1996, the Company has estimated operating loss
carry forwards of approximately $4.9 million for Federal income tax
purposes, which expire from 2005 to 2010 and approximately $6.6 million for
state income tax purposes, which expire from 2005 to 2010, and are
available to reduce future income taxes.

9
<PAGE>

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

The Company provides comprehensive managed health care services
through wholly owned subsidiary companies. The behavioral health services
are composed of the management of mental health services and substance
abuse care on behalf of self-insured employers, health maintenance
organizations, insurance companies and government agencies in different
states. The Company not only manages such care but also provides where
appropriate the delivery of care through integrated systems involving
clinics and other providers. These services range from benefit design,
case management and claims processing to fully capitated (at risk) mental
health care treatment.

At September 30, 1996, the Company operated in 10 states and has a
strategy to consolidate its behavioral health operations through
development and joint venture efforts in various regions of the country in
which it currently operates.

On November 5, 1996, the Company announced that it had entered into an
agreement for the sale of its discontinued HMO operation (see "Item 5 -
Other Information" below) .

In connection with the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995, the Company notes that this
Quarterly Report on Form 10-QSB contains forward-looking statements about
the Company. The Company is hereby setting forth cautionary statements
identifying important factors that may cause the Company's actual results
or condition to differ materially from those set forth in any forward-
looking statement. Some of the most significant factors include (i) the
Company's inability to dispose of its HMO operation, (ii) the effects of
competition on the Company's business, including the loss of a major
customer or the loss of members of its provider network of physicians,
hospitals, and other healthcare providers, and (iii) statutory, regulatory
and administrative changes or interpretations of existing statutory and
regulatory provisions affecting the conduct of the Company's businesses, or
the failure to obtain exemptions from the existing statutory or regulatory
provisions. Accordingly, there can be no assurances that any anticipated
future results or condition will be achieved.

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, certain
items of the Company's consolidated statements of operations as a
percentage of the Company's net revenues from continuing operations.

10
<PAGE>

PERCENTAGE OF NET REVENUE
QUARTER ENDED
SEPTEMBER 30
1996 1995(a)
------------- --------------
<S> <C> <C>

Net revenues.................................. 100.0 % 100.0 %
------ ------
Operating expenses:
Contracted provider services.................. 41.6 % 35.0 %
Salaries, wages and benefits.................. 37.6 % 46.3 %
Management fees charged by related companies.. 1.5 % 1.5 %
Other operating expenses...................... 19.3 % 24.7 %
Depreciation and amortization................. 6.1 % 6.3 %
Interest and other financing charges.......... 4.1 % 3.9 %
------ ------
Total operating expenses...................... 110.2 % 117.7 %
------ ------

Loss from continuing opertaions before
income taxes................................ (10.2)% (17.7)%
====== ======

</TABLE>

(a) Certain amounts for the quarter ended September 30, 1995 have been
reclassified to reflect the Company's discontinued HMO operation.

QUARTER ENDED SEPTEMBER 30, 1996
COMPARED TO QUARTER ENDED SEPTEMBER 30, 1995

Net revenues in the quarter ended September 30, 1996, were $5.80
million compared to $4.70 million in the comparable quarter of the prior
fiscal year. The increase in net revenues is attributable to new or
expanded managed care contracts obtained, in particular in North Carolina
effective October 1995 and Texas effective September 1996. Clinical and
other clinical service revenue increased as a result of new clinics opened
during calendar year 1995.

Contracted provider services expenses increased to $2.40 million in
the September quarter of 1996 compared to $1.65 million in the prior year
September quarter as a result of the increased number of members whose care
is managed by the Company.

Other operating expenses comprising salaries and wages, and general
and administrative expenses decreased from $3.45 million to $3.30 million
reflecting the increasing efficiencies and cost management in the
operations base of the Company's managed behavioral health division.

The Company recorded a loss before income taxes of $592,000 compared
to a loss of $834,000 incurred in the same quarter in the prior year. The
Company's results continue to be impacted by general corporate costs,
increased interest and amortization expenses, as well as continuing start
up-costs in the clinical operations of the Company.

11
<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

General. In connection with the Distribution of the Company's
common stock on April 24, 1995 by Ramsay Health Care, Inc. ("RHCI") to its
shareholders (the "Distribution"), the Company and RHCI entered into the
Second Amended and Restated Distribution Agreement (the "Distribution
Agreement"). Pursuant to the Distribution Agreement, each of RHCI and RMCI
has agreed to pay to the other the net amount of all outstanding
intercompany receivables and payables as of April 24, 1995 (other than
those evidenced by the $6 million unsecured subordinated promissory note
issued by RMCI to RHCI representing certain advances made by RHCI to or on
behalf of RMCI (the "Subordinated Promissory Note") which are governed by
the terms thereof). As of September 30, 1996, RMCI owed RHCI approximately
$2.1 million in relation to these items, and in addition, accrued interest
on the Subordinated Promissory Note of $480,000. See the discussion below
under "Indebtedness" concerning RHCI's agreement not to require repayment
of net cash advances and accrued interest on the Subordinated Promissory
Note until after October 1997.

During the quarter ended September 30, 1996, the Company used net
cash of $73,000 in its continuing operations. The Company anticipates that
its sources of liquidity during fiscal 1997 primarily will be its cash flow
from continuing operations, funds anticipated to be received from the sale
of its HMO operation, the proceeds from a $3 million private placement of
preferred stock discussed under "Indebtedness" below and advances from an
affiliate discussed under "Indebtedness" below. See also "Item 5 -Other
Information" below.

The Company expects to use its sources of liquidity for working
capital and other general corporate purposes, including for the payment of
costs and expenses discussed above and costs associated with the
establishment and development of its managed mental healthcare business.

There can be no assurance that the Company will expand its
operations by development, acquisition or internal expansion or that any
development effort, acquisition or expansion will be profitable.

As discussed below (see "Indebtedness") the Company believes that it
may require additional funds for working capital and general corporate
purposes.

Financing. On April 26, 1996, the Company amended its credit
facility (the "Credit Facility") with the First Union National Bank of
Florida (the "Bank"). A previous Revolving Credit Facility for up
$4,200,000 was replaced by a $1,500,000 Revolving Master Line of Credit
(the "Master Revolver") and a $100,000 Term Loan.

The Master Revolver will expire on December 31, 1996 and the
$100,000 Term Loan is repayable in 36 level monthly principal payments of
$2,777.70, plus interest. At September 30, 1996, $1,500,000 was
outstanding under the Master Revolver. The Master Revolver bears interest
at the following rates, as applicable and selected by the Company from time
to time: (i) the Bank's LIBOR adjusted rate plus

12
<PAGE>

3.0% or (ii) the Bank's prime rate plus 0.75%. The $100,000 Term Loan
bears interest at the Bank's prime rate plus 1.0%.

In October 1996, the Credit Facility was further amended pursuant to
which Apex Healthcare, Inc., a wholly owned subsidiary of the Company,
guaranteed the obligations of the Company under the Credit Facility and the
Company pledged all of the shares of capital stock of Apex to the Bank as
collateral.

As part of the acquisition of FPM in October 1993, the Company
issued 7% three year debentures, totaling $2,500,000 (see "Indebtedness"
below). These debentures were prepaid with the proceeds of a $1,667,000
three year secured term loan from the Bank on April 28, 1995. This three
year term loan bears interest at (i) the Bank's LIBOR adjusted rate plus
2.5% or (ii) the bank's prime rate plus 0.50%, as selected by the Company.
Principal on this three year term loan is payable quarterly with a final
maturity of January 31, 1998. This three year secured term loan, the
additional term loan of $100,000 (referred to above) and the Master
Revolver are secured by a pledge of the stock of RMCI's subsidiaries and
the assets of RMCI's subsidiaries, and are required to be repaid with a
portion of the proceeds from the sale of the Company's HMO operation.

The Credit Facility contains covenants customary for facilities of
this type, which include, without limitation, covenants which contain
limitations on the ability of FPM and its subsidiaries, subject to certain
exceptions, to (i) assume or incur liens, (ii) alter the nature of their
business or effect mergers, consolidations, or sales of assets, (iii) incur
indebtedness or make investments, (iv) acquire businesses, or (v) pay
dividends to the Company . In addition, the Credit Facility contains
financial covenants related to senior debt to cash flow, interest coverage,
and minimum stockholders' equity. At June 30, 1996, FPM's minimum
stockholders' equity ratio was less than the requirement. The Bank agreed
to waive this requirement for the year ended June 30, 1996.

Indebtedness. In connection with the Company's acquisition of all
the outstanding shares of common stock of FPM in October 1993, FPM issued
7% debentures due October 31, 1996 (the "Debentures") in the aggregate
principal amount of $2,500,000 to the selling stockholders of FPM,
including Martin Lazoritz, Robert W. Pollack and I. Paul Mandelkern,
officers of the Company or its subsidiaries. Subsequently, on April 28,
1995, these Debentures were prepaid with the proceeds of the $1,667,000
three year secured term loan discussed above.

In connection with the Company's acquisition of the assets of HDI,
through a wholly owned subsidiary FPMBH of Arizona, Inc., the Company
issued a promissory note in the principal amount of $1,000,000 (the "HDI
Note") to Phoenix South Community Mental Health Centers ("Phoenix South").
Interest accrues on the HDI Note at a fixed rate of 8.25% per annum and is
payable monthly in arrears, together with equal installments of principal,
until the HDI Note matures on June 30, 1997. The HDI Note is secured
pursuant to a Stock Pledge Agreement dated June 30, 1994, pursuant to which
Phoenix South has a first priority lien on all of the common stock of FPMBH
of Arizona, Inc. (f/k/a Ramsay HDI). Upon payment in full of the HDI Note,
the Bank

13
<PAGE>

will have a first priority lien on the common stock of FPMBH of Arizona
under the Credit Facility.

In addition, in connection with the Distribution of RMCI from RHCI,
RMCI issued to RHCI the Subordinated Promissory Note in the principal
amount of $6,000,000, evidencing certain funds advanced to or on behalf of
RMCI by RHCI, including in connection with the acquisition of certain
acquired businesses. Prior to its issuance, the amounts evidence by the
Subordinated Promissory Note were recorded as intercompany indebtedness
between RMCI and RHCI. Interest accrues on the Subordinated Promissory
Note at an annual fixed rate of 8%.

The Subordinated Promissory Note is unsecured and is subordinated
and junior in right of payment to all indebtedness of RMCI and its
subsidiaries incurred in connection with the acquisition of HDI and future
acquisitions of other managed mental health care services businesses, and
any other Senior Indebtedness (as defined in the Subordinated Promissory
Note), including indebtedness arising under the Credit Facility and any
other bank indebtedness of RMCI or its subsidiaries. At the present time,
Senior Indebtedness outstanding is comprised of the HDI Note, the three
year secured term note to the Bank and amounts due under the Credit
Facility.

In September 1996, RHCI and RMCI commenced negotiations to
restructure the payment terms associated with the net cash advances from
RHCI totaling $2.1 million as at September 30, 1996, the interest due on
the Subordinated Promissory Note for the year ending June 30, 1997 and the
$480,000 of interest accrued on the Subordinated Promissory Note from
October 1995 to September 30, 1996. Of the $6,000,000 due on the
Subordinated Promissory Note, approximately $1,400,000 is due on or before
June 30, 1997 and the remainder is payable in 13 quarterly installments of
approximately $353,000, beginning September 30, 1997. RHCI has agreed not
to require repayment of the interest on the Subordinated Promissory Note
for the period October 1, 1995 through September 30, 1996 or the net cash
advances until after October 1, 1997, all on terms and conditions to be
mutually agreed upon.

As of June 30, 1996, the aggregate amount of principal on the
Company's indebtedness payable during the fiscal year of the Company ending
June 30, 1997 and during each of the next four fiscal years of the Company
will be approximately $2,334,000, $2,001,000, $1,437,000, $1,412,000, and
$352,000, respectively.

In June 1996, at the request of RMCI, Paul Ramsay Hospitals Pty.
Limited ("Ramsay Hospitals"), a corporate affiliate of Paul J. Ramsay, the
Chairman of the Board of the Company, agreed to loan RMCI up to $3,000,000
for working capital and general corporate purposes. On June 28, 1996, RMCI
borrowed $1,600,000, which was evidenced by a demand promissory note (the
"First Hospitals Note") payable to Ramsay Hospitals with an interest rate
of 12% per annum. In addition, on August 7 and August 8, 1996, RMCI
borrowed an aggregate of $800,000, which was evidenced by a demand
promissory note (the "Second Hospitals Note") payable to Ramsay Hospitals
in the principal amount of the lesser of the amount borrowed or $1,400,000,
with an interest rate of 12% per annum. On September 10, 1996, as describe
below, the First Hospitals Note and the Second Hospitals Note were repaid
and canceled.

14
<PAGE>

On September 10, 1996, RMCI entered into a stock purchase agreement
with Ramsay Hospitals, pursuant to which Ramsay Hospitals purchased 100,000
shares of Series 1996 Convertible Preferred Stock at a purchase price of
$3,000,000. The purchase price was paid by (i) offset against the
outstanding principal amounts under the First Hospitals Note and the Second
Hospitals Note ($1,600,000 and $800,000, respectively), (ii) offset against
the aggregate accrued unpaid interest on such notes through September 10,
1996 ($54,667) and (iii) $545,333 in cash. In connection with the purchase
of the 100,000 shares of Series 1996 Convertible Preferred Stock by Ramsay
Hospitals, RMCI issued warrants to Ramsay Hospitals to purchase 300,000
shares of Common Stock, at an exercise price of $1.00 per share.

In September 1996, a corporate affiliate of Mr. Ramsay formalized
its agreement to provide an additional loan facility, if required, of up to
$2,000,000 to the Company for working capital and general corporate
purposes. Borrowings under this facility will bear interest at 15% per
annum and the Company has agreed to pay Ramsay Hospitals a $100,000
facility fee in consideration for making the facility available to the
Company. At November 1, 1996, $600,000 was borrowed by the Company under
the facility.

The Company may be required to raise additional funds for working
capital, general corporate purposes, development and growth beyond its
immediate plans and/or to remain competitive with its larger competitors.
Any additional equity financing may result in substantial dilution to the
stockholders of the Company. Except for the financing provided by the above
mentioned affiliate commitment and the Master Revolver (which at September
30, 1996 was fully drawn), the Company has made no arrangements to obtain
any additional debt financing, and there can be no assurance that the
Company will be able to obtain any required additional funds.

15
<PAGE>

PART II - OTHER INFORMATION

ITEM 5. OTHER INFORMATION

The Company has agreed to sell all of the issued and outstanding
shares of common stock, $.01 par value (the "Apex Shares"), of Apex
Healthcare, Inc. ("Apex"), a Delaware corporation and wholly owned
subsidiary of the Company, to RoTech Medical Corporation ("RoTech"), a
Delaware corporation, pursuant to a Stock Purchase Agreement dated as of
October 30, 1996. Apex is engaged in the business of operating HMOs and
related businesses in the states of Alabama, Louisiana and Mississippi.
The purchase price for the Apex Shares is $4,350,000. The closing of the
sale is subject to the receipt of regulatory approvals, third-party
consents and other customary closing conditions. The determination of the
consideration for the sale of Apex Shares was based on negotiations between
the Company and RoTech.

16
<PAGE>

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits

The exhibits required to be filed as part of this Quarterly Report
on Form 10-QSB are listed on the attached Index to Exhibits.

(b) Current Reports on Form 8-K

There were no Current Reports on Form 8-K filed with the
Commission during the quarter ended September 30, 1996. On
October 2, 1996, the Company filed a Current Report on Form 8-K
with the Commission.

17
<PAGE>

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereupon duly authorized.

RAMSAY MANAGED CARE, INC.
Registrant

/s/ Warwick D. Syphers
---------------------------
Warwick D. Syphers
Chief Financial Officer

Date: November 19, 1996

18
<PAGE>

RAMSAY MANAGED CARE, INC.

INDEX TO EXHIBITS

EXHIBIT
NUMBER DESCRIPTION
- ------ -----------

2.1 Stock Purchase Agreement dated as of October 30, 1996 by and among
Apex Healthcare, Inc., Ramsay Managed Care, Inc. and RoTech Medical
Corporation. Pursuant to Reg. S-B, Item 601(b)(2), the Company agrees
to furnish a copy of the Disclosure Schedules to such Agreement to
the Commission upon request.

11 Computation of Net Income (Loss) per Share.

27 Financial Data Schedule.

<PAGE>

Exhibit 2.1
================================================================================

STOCK PURCHASE AGREEMENT

By and Among

Apex Healthcare, Inc.,

Ramsay Managed Care, Inc.

and

RoTech Medical Corporation

As of October 30, 1996

================================================================================
<PAGE>

TABLE OF CONTENTS

Page

SECTION I PURCHASE AND SALE OF THE SHARES...... 1

A. Purchase and Sale of the Shares...... 1
B. Purchase Price for Shares............ 2
C. Discharge of Indebtedness............ 2

SECTION II REPRESENTATIONS AND WARRANTIES OF THE
SHAREHOLDER.......................... 2

A. Organization; Qualification.......... 2
B. Due Authorization.................... 3
C. No Conflicts......................... 4
D. Capital Stock........................ 4
E. Financial Statements................. 4
F. Changes Since June 30, 1996.......... 4
G. Dividends; Discharge of Indebtedness. 5
H. Properties........................... 6
I. Litigation........................... 6
J. Taxes................................ 7
K. Permits.............................. 7
L. Equipment............................ 8
M. Accounts Receivable.................. 8
N. Contracts; Other Obligations and
Liabilities.......................... 8
O. Directors, Officers and Employees.... 9
P. ERISA and Related Matters............ 9
Q. Labor................................ 12
R. Compensation......................... 12
S. Insurance............................ 13
T. Restrictions on Business............. 13
U. Patents and Trademarks............... 13
V. Power of Attorney.................... 13
W. Accounts Payable..................... 13
X. Bank Accounts........................ 13
Y. Books and Records.................... 14
Z. Brokers.............................. 14
AA. Medicare and Medicaid................ 14
BB. Consents............................. 15

SECTION III REPRESENTATIONS AND WARRANTIES OF THE
PURCHASER............................ 15

A. Organization; Qualification.......... 15
B. Due Authorization.................... 16
C. No Conflicts......................... 16
D. Investment........................... 16
E. Funds................................ 17
<PAGE>

PAGE
----

SECTION IV ADDITIONAL REPRESENTATIONS AND
WARRANTIES OF THE SHAREHOLDER........ 17

A. Organization; Qualification.......... 17
B. Due Authorization.................... 17
C. No Conflicts......................... 18
D. Ownership of Shares, etc............. 18

SECTION V COVENANTS OF THE COMPANY............. 18

A. Negative Covenants................... 18

SECTION VI COVENANTS OF THE PURCHASER........... 21

A. General.............................. 21
B. Employees............................ 21

SECTION VII ADDITIONAL AGREEMENTS................ 22

A. Appropriate Action; Consents; Filings 22
B. Tax Matters.......................... 24
C. Employment Agreements................ 24
D. Affiliate Leases..................... 24

SECTION VIII CLOSING.............................. 25

A. Time and Place of Closing............ 25
B. Delivery of Shares................... 25

SECTION IX CONDITIONS TO THE OBLIGATIONS OF THE
SHAREHOLDER.......................... 25

SECTION X CONDITIONS TO THE OBLIGATIONS OF THE
PURCHASER............................ 26

SECTION XI INDEMNIFICATION...................... 29

A. Indemnification by the Shareholder... 29
B. Indemnification by the Purchaser..... 29
C. Procedure for Indemnification........ 30
D. Limitation on Indemnification........ 31
E. Subrogation.......................... 31

SECTION XII MISCELLANEOUS........................ 32

A. Notices.............................. 32
B. Survival of Representations.......... 33
C. Entire Agreement; Modifications...... 33
D. Reasonable Best Efforts.............. 33
E. Expenses............................. 33

ii
<PAGE>

F. Enforceability....................... 33
G. Termination.......................... 34
H. Definitions.......................... 34
I. Survival of Covenants and Agreements 35
J. Return of Documentation.............. 35
K. Meaning of "Knowledge"............... 35
L. Successors and Assigns............... 35
M. Governing Law........................ 36
N. Counterparts......................... 36
O. Headings............................. 36

EXHIBITS

Exhibit A Escrow Agreement
Exhibit B Opinion of Counsel to the Purchaser
Exhibit C Opinion of Counsel to the Shareholder

iii
<PAGE>

STOCK PURCHASE AGREEMENT

AGREEMENT made as of the 30th day of October, 1996 by and among Apex
Healthcare, Inc., a Delaware corporation (the "Company"), Ramsay Managed Care,
Inc., a Delaware corporation (the "Shareholder") and the holder of all of the
issued and outstanding shares of the common stock, $.01 par value per share, of
the Company (the "Common Stock"), and RoTech Medical Corporation, a Delaware
corporation (the "Purchaser").

W I T N E S S E T H:
- - - - - - - - - -

WHEREAS, the Company and its subsidiaries are engaged, among other
things, in the business of owning and operating health maintenance organizations
and related activities in the States of Alabama, Louisiana and Mississippi (such
activities being hereinafter referred to as the "Business");

WHEREAS, the Shareholder is the holder of 1,000 shares of Common
Stock, which shares constitute all of the issued and outstanding shares of
capital stock of the Company (all such shares of Common Stock held by the
Shareholder being hereinafter referred to as the "Shares"); and

WHEREAS, the Purchaser desires to acquire from the Shareholder all of
the Shares and the Shareholder desires to sell all of the Shares to the
Purchaser, on the terms and subject to the conditions hereinafter set forth.

NOW, THEREFORE, in consideration of the premises and the mutual
covenants and agreements hereinafter set forth, and intending to be legally
bound, the parties hereto hereby agree as follows:

SECTION I
---------

PURCHASE AND SALE OF THE SHARES
-------------------------------

A. Purchase and Sale of the Shares. Subject to the terms and
-------------------------------
conditions of this Agreement and on the basis of the representations,
warranties, covenants and agreements herein contained, at the Closing (as
hereinafter defined), the Shareholder agrees to sell, assign and convey to the
Purchaser, and the Purchaser agrees to purchase, acquire and accept from the
Shareholder, all of the Shares.
<PAGE>

B. Purchase Price for Shares. The purchase price (the "Purchase
-------------------------
Price") for the Shares shall be the sum of (i) $4,000,000, plus (ii) the
Purchase Price Adjustment (as hereinafter defined), plus (iii) the amount of any
increase in restricted regulatory reserves of the Company and its subsidiaries
for Alabama, Louisiana and Mississippi specifically mandated by applicable
regulatory body and funded by the Shareholder or its affiliates after the date
hereof. At the Closing, $350,000 of the Purchase Price shall be paid by wire
transfer to the Escrow Account as defined in the Escrow Agreement (the "Escrow
Agreement") among the Shareholder, the Company, the Purchaser and the Escrow
Agent named therein, in the form attached hereto as Exhibit A, for payment as
provided in the Escrow Agreement, and the balance of the Purchase Price shall be
paid by wire transfer of immediately available funds to the account or accounts
designated by the Shareholder. As used herein, the "Purchase Price Adjustment"
shall mean the amount of $350,000 payable in consideration of marketing activity
heretofore undertaken by the Company consistent with Section II(F)(vi) with
respect to the groups listed in the Company Disclosure Schedule.

C. Discharge of Indebtedness. Concurrent with and as part of the
-------------------------
Closing, upon payment by the Purchaser of the Purchase Price as provided in
Section I(B), the Shareholder shall cause all documents and instruments to be
executed, delivered and/or filed as the case may be in recordable form as
appropriate, necessary to fully release all indebtedness of the Company to the
Shareholder, together with all liens, security interests, pledges and other
encumbrances securing the same.

SECTION II
----------

REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDER
-------------------------------------------------

The Shareholder hereby represents and warrants to the Purchaser as of
the date hereof that, except as set forth in the Company Disclosure Schedule:

A. Organization; Qualification. (i) The Company is duly organized,
---------------------------
validly existing and in good standing under the laws of the State of Delaware
and has full corporate power and authority to own its properties and to conduct
the businesses in which it is now engaged. The Company is qualified to do
business and in good standing in each other jurisdiction where it is presently
conducting business wherein the failure so to qualify would have a material
adverse effect on the businesses or properties of the Company. The Company has
full power, authority and
<PAGE>

legal right and all necessary consents, approvals, permits, licenses and
authorizations to own its properties and to conduct the Business. Complete and
correct copies of the certificate of incorporation and by-laws of the Company
have been delivered to the Purchaser.

(ii) Set forth in the Company Disclosure Schedule is a complete and
correct list of all of the Company's subsidiaries, showing for each subsidiary
the jurisdiction of its incorporation, each jurisdiction where it is qualified
to do business, the number of shares of each class of its capital stock
authorized, the number of shares of each class issued and outstanding and the
number of shares of each class owned by the Company. All of the securities of
each of the subsidiaries owned by the Company are free and clear of all liens,
charges, pledges, security interests or other encumbrances and claims, and all
of the capital stock of such subsidiaries owned by the Company have been duly
authorized and validly issued and are fully paid and non-assessable. Each of
the Company's subsidiaries is a corporation duly organized, validly existing and
in good standing under the laws of its jurisdiction of incorporation, has the
corporate power and all necessary authorizations to own all of its properties
and assets and to carry on its business and is duly qualified to do business and
is in good standing in each jurisdiction in which it owns property or conducts
business and in which its failure to be so qualified would materially adversely
affect the business, operations or financial condition of the Company or any
subsidiary. Each of the Company's subsidiaries has full power, authority and
legal right and all necessary consents, approvals, permits, licenses and
authorizations to own its properties and to conduct its business as presently
conducted. Complete and correct copies of the certificate of incorporation and
by-laws of each subsidiary of the Company have been delivered to the Purchaser.

B. Due Authorization. The execution and delivery of this Agreement by
-----------------
the Company, the performance by the Company of its covenants and agreements
hereunder and the consummation by the Company of the transactions contemplated
hereby have been duly authorized by all necessary corporate action. This
Agreement constitutes the valid and legally binding obligation of the Company
enforceable against the Company in accordance with its terms, except as
enforceability may be limited by bankruptcy, insolvency, reorganization or other
similar laws affecting creditors' rights generally or by general principles of
equity.
<PAGE>

C. No Conflicts. Neither the execution and delivery of this Agreement,
------------
nor the consummation of the transactions contemplated hereby, violates any
provision of the certificate of incorporation or by-laws of the Company or any
of its subsidiaries or, subject to the receipt of the necessary governmental and
regulatory approvals as set forth in Schedule II(BB) of the Company Disclosure
Schedule, any statute, ordinance, regulation, order, judgment or decree of any
court or Governmental Authority, or conflicts with or will result in any breach
of any of the terms of or constitute a default under or result in the
termination of or the creation of any lien pursuant to the terms of any contract
or agreement to which the Company is a party or by which the Company or any of
its subsidiaries or any of the assets of the Company or any of its subsidiaries
is bound.

D. Capital Stock. The authorized capital stock of the Company consists
of 1,000 shares of Common Stock, all of which shares are issued and outstanding.
All of the outstanding shares of Common Stock have been validly issued and are
fully paid and non-assessable. There are no subscriptions, warrants, options,
calls, debt instruments, commitments or agreements to which the Company is bound
relating to the issuance, sale or redemption of shares of the Common Stock or
other securities of the Company.

E. Financial Statements. The Company has delivered to the Purchaser
--------------------
unaudited consolidated financial statements of the Company for the fiscal year
ended June 30, 1996, together with the related balance sheets and statements of
income (the "Company Financial Statements"). The Company Financial Statements
are true and correct in all material respects and have been prepared in
accordance with generally accepted accounting principles applied consistently
throughout the periods involved, other than the absence of notes to the Company
Financial Statements. The Company Financial Statements fully and fairly present
the consolidated financial condition of the Company as at the dates thereof and
the consolidated results of the operations of the Company for the periods
indicated. The balance sheets contained in the Company Financial Statements
fairly reflect all assets and liabilities of the Company and its subsidiaries of
the types normally reflected in balance sheets as at the respective dates
thereof. For purposes of this Section II(E), an amount greater than $10,000 with
respect to any item shall be deemed material. A complete and correct copy of the
Company Financial Statements has been delivered to the Purchaser.

F. Changes Since June 30, 1996. Subsequent to June 30, 1996, there has
---------------------------
not been any material (i) adverse
<PAGE>

change in the operations, operating results, business or condition (financial or
otherwise) of the Company or any of its subsidiaries or in the results of the
operations of the Company or any of its subsidiaries, it being understood that
changes resulting from continuing losses in the normal course of business
consistent with prior operating results shall not be deemed a material adverse
change; (ii) damage or destruction (whether or not insured) affecting the
properties or business operations of the Company or any of its subsidiaries;
(iii) labor dispute or threatened labor dispute involving the employees of the
Company or any of its subsidiaries; (iv) adverse development with respect to any
permits, licenses or other authorizations now held by the Company or any of its
subsidiaries necessary to operate the Business; (v) actual or threatened
disputes pertaining to the Company or any of its subsidiaries with any major
accounts or referral sources of the Company or any of its subsidiaries, or
actual or threatened loss of business from any of the major accounts or referral
sources of the Company or any of its subsidiaries; or (vi) changes in the
methods or procedures for billing or collection of customer accounts or
recording of customer accounts receivable, reserves for doubtful accounts or
contractual allowances with respect to the Company or any of its subsidiaries,
or changes in medical underwriting methodology. For purposes of this Section
II(F), an amount greater than $10,000 with respect to any item shall be deemed
material; provided, however, that as to changes in medical underwriting
methodology under clause (vi) of the preceding sentence, any amount greater than
$200 in any individual event or $10,000 cumulatively shall be deemed material.

G. Dividends; Discharge of Indebtedness. Subsequent to June 30, 1996,
------------------------------------
the Company has not declared or paid any dividend or made any other distribution
in respect of the Common Stock, or, directly or indirectly, purchased, redeemed
or otherwise acquired or disposed of any shares of the Common Stock; and the
Company and its subsidiaries have not, except in the ordinary course of
business, paid or discharged any outstanding indebtedness. Subsequent to June
30, 1996, the Company and its subsidiaries have paid all amounts due and payable
(i) of bank and other indebtedness, (ii) under leases and contractual
obligations and (iii) to any persons in the ordinary course of business.
Subsequent to June 30, 1996, the Company and its subsidiaries have not (x)
incurred any bank or other indebtedness for borrowed money, (y) entered into any
(A) loan agreements or (B) any material leases or material contracts,
obligations or arrangements for the payment of money or property to any person
other than in the ordinary course of business consistent with prior practice of
the Company or such
<PAGE>

subsidiary, as the case may be, or (z) permitted any material liens or
encumbrances to attach to their assets. For purposes of this Section II(G), any
lease, contract, obligation or arrangement requiring the potential payment in
one or more installments of greater than $10,000, or any lien or encumbrance
securing obligations of greater than $10,000 in the aggregate, shall be deemed
material.

H. Properties. (i) The Company or its subsidiaries lease or own all
----------
real properties and lease or own all other properties and assets used in the
operation of the Business as currently conducted. The Company Disclosure
Schedule contains a description of such properties and assets and the
description is true and complete in all material respects. All such properties
and assets are in all material respects in good condition and repair, consistent
with their respective ages, and have been maintained and serviced in accordance
with normal practices of the Company and as necessary in the normal course of
business. Such owned properties or assets, and the Company's and its
subsidiaries' interests in any of such leased properties or assets, are not
subject to any liens, charges, encumbrances or security interests. None of such
properties or assets (or the uses to which they are put) fails to conform in any
material respect with any applicable law, ordinance or regulation. For purposes
of this Section II(H), any asset valued at greater than $5,000 (valued at the
greater of book value or fair market value) shall be deemed a material asset.

(ii) The Company and its subsidiaries have duly complied with, and to
the knowledge of the Shareholder, all the real estate now owned or leased by the
Company or any of its subsidiaries and the improvements thereon are in
compliance with, the provisions of all federal, state and local environmental,
health and safety laws, codes and ordinances and all rules and regulations
promulgated thereunder as to which a default or failure to comply might result
in a material adverse change in the condition (financial or otherwise) of the
Company or any of its subsidiaries or the assets of the Company or any of its
subsidiaries, taken as a whole in each case.

I. Litigation. There are no material claims, disputes, actions,
----------
suits, proceedings or investigations currently filed, commenced or, to the
knowledge of the Shareholder, threatened against or affecting the Company or any
of its subsidiaries. Neither the Company nor any of its subsidiaries is in
default under any, and each of the Company and each of its subsidiaries has
complied with all, statutes, ordinances, regulations, orders, judgments and
<PAGE>

decrees of any court or other Governmental Authority relating to the Company or
any of its subsidiaries or the assets of the Company or any of its subsidiaries
as to which a default or failure to comply might result in any material adverse
change in the condition of the Company or any of its subsidiaries or the assets
of the Company or any of its subsidiaries, taken as a whole in each case, and
the Shareholder has no knowledge of any basis for any claim for compensation or
damages or otherwise arising out of any violation of the foregoing. For
purposes of this Section II(I), an amount greater than $5,000 with respect to
any item shall be deemed material.

J. Taxes. The Company and each of its subsidiaries have filed or
-----
caused to be filed all tax returns, reports and declarations required to be
filed by them and have paid all taxes, including, but not limited to, income,
franchise, sales, use, unemployment, withholding, social security and worker's
compensation taxes and estimated income and franchise tax payments, and
penalties and fines due and payable with respect to the periods covered by said
returns, reports or declarations or pursuant to any assessment received by them
in connection with such returns, reports or declarations. Since the inception
of the Company, the taxable income of the Company and its subsidiaries has been
included in the consolidated Federal income tax returns of the Shareholder to
the extent required to be so included under the Internal Revenue Code of 1986,
as amended (the "Code"). No deficiency in payment of any taxes for any period
has been asserted by any taxing authority which remains unsettled at the date
hereof and there is no basis for any additional claims or assessments for taxes.
The Company has made available to the Purchaser for its review complete and
correct copies of the income (or franchise) tax returns filed by it and each of
its subsidiaries.

K. Permits. The Company Disclosure Schedule contains a correct and
-------
complete list of each material license, permit, certificate, approval,
franchise, registration, accreditation or authorization issued to the Company
and its subsidiaries or used in the Business, including the licenses of the
Company and/or the subsidiaries to operate health maintenance organizations
under the applicable HMO Act. Each of the Company and its subsidiaries has all
material permits, licenses, orders and approvals of all Federal, state or local
governmental or regulatory bodies required for it to conduct the Business as
presently conducted; all such material permits, licenses, orders and approvals
are in full force and effect and, to the knowledge of the Shareholder, no
suspension or
<PAGE>

cancellation of any of them is threatened; and as of the Closing none of such
permits, licenses, orders or approvals will be adversely affected by the
consummation of the transactions contemplated by this Agreement. The Company
and its subsidiaries have complied in all material respects with all statutes,
rules and regulations applicable to them, including, without limitation, those
concerned with medical devices, occupational safety, environmental protection
and employment practices, and the Company has not received notice of any
material violation of any such statutes, rules or regulations, within the last
three years, which has not been corrected.

L. Equipment. The Company Disclosure Schedule contains a correct and
---------
complete list of all equipment owned or leased by the Company and its
subsidiaries. The equipment of the Company and its subsidiaries is in the
aggregate in all material respects usable in the ordinary course of business.

M. Accounts Receivable. The accounts receivable of the Company and
-------------------
its subsidiaries are in their entirety bona fide accounts receivable, arising in
the ordinary course of business.

N. Contracts; Other Obligations and Liabilities. Set forth in the
--------------------------------------------
Company Disclosure Schedule is a list and brief description of all (i) material
contracts, agreements, licenses, leases, arrangements (written or oral) and
other documents to which the Company or one or more of its subsidiaries is a
party or by which the Company or one or more of its subsidiaries or any of the
assets of the Company or one or more of its subsidiaries is bound (including, in
the case of loan agreements, a description of the amounts of any outstanding
borrowings thereunder and the collateral, if any, for such borrowings); (ii)
material obligations and liabilities of the Company or any of its subsidiaries
pursuant to uncompleted orders for the purchase of materials, supplies,
equipment and services for the requirements of the Business; and (iii) all
material contingent obligations and liabilities of the Company or any of its
subsidiaries, including, without limitation, any and all Medicare and Medicaid
rebate claims out of the ordinary course of business; all of the foregoing being
hereinafter referred to as the "Contracts." Neither the Company nor any of its
subsidiaries is in material default in the performance of any covenant or
condition under any Contract and no claim of such a material default has been
made. Originals or true, correct and complete copies of all the Contracts have
been provided to the Purchaser and its counsel as of the date hereof. For
purposes of this Section
<PAGE>

II(N), a Contract is deemed to be "material" if it (together with any related
Contracts) involves the potential payment to or by the Company in one or more
installments of an amount greater than $5,000 and is not entered into in the
ordinary course of business.

O. Directors, Officers and Employees. Set forth in the Company
---------------------------------
Disclosure Schedule is a list of the directors and officers of the Company and
of each subsidiary of the Company and their respective positions and salaries as
of the date hereof and of the other employees of the Company and its
subsidiaries and their respective salaries as of the date hereof. Set forth in
the Company Disclosure Schedule is a list of all agreements (whether written or
oral) with regard to compensation or employment between the Shareholder, the
Company or any of the Company's subsidiaries and the Company's employees.

P. ERISA and Related Matters.
-------------------------

(a) Except as set forth in the Company Disclosure Schedule, neither
the Company, nor any ERISA Affiliate of the Company, is a party to or
participates in or has any liability or contingent liability with respect to:

(i) any "employee welfare benefit plan" or "employee pension
benefit plan" or "multiemployer plan" (as those terms are respectively
defined in Sections 3(1), 3(2) and 3(37) of the Employee Retirement
Income Security Act of 1974, as amended ("ERISA")); or

(ii) any retirement or deferred compensation plan, incentive
compensation plan, stock plan, unemployment compensation plan,
vacation pay, severance pay, bonus or benefit arrangement, insurance
or hospitalization program or any other fringe benefit arrangements
for any employee, director, consultant or agent, whether pursuant to
contract or arrangement, which does not constitute an "employee
benefit plan" (as defined in Section 3(3) of ERISA).

Any plan, arrangement or agreement required to be listed on the
Company Disclosure Schedule for which the Company or any ERISA Affiliate of the
Company may have any liability or contingent liability is sometimes hereinafter
referred to as a "Benefit Plan". For purposes of this Section, the term "ERISA
Affiliate" of the Company shall mean any subsidiary of the Company and any other
trade or business, whether or not incorporated, that together with
<PAGE>

the Company or with any subsidiary of the Company would be deemed a "single
employer" within the meaning of Section 4001(b)(i) of ERISA.

(b) A true and correct copy of each of the Benefit Plans listed on the
Company Disclosure Schedule, and all contracts relating thereto, or to the
funding thereof, including, without limitation, all trust agreements, insurance
contracts, investment management agreements, subscription and participation
agreements and recordkeeping agreements, each as in effect on the date hereof,
has been delivered to the Purchaser. In the case of any Benefit Plan that is
not in written form, the Purchaser has been supplied with an accurate
description of such Benefit Plan as in effect on the date hereof.

(c) As to all Benefit Plans, except as otherwise specified on the
Company Disclosure Schedule or except as would not have a material adverse
effect on the Company or its subsidiaries:

(i) All Benefit Plans comply, and have been administered in
form and in operation in all material respects, with all requirements
of law and regulations applicable thereto, including without
limitation the timely filing of all annual reports required with
respect to such Benefit Plans, and neither the Shareholder, the
Company nor any ERISA Affiliate of the Company has received any notice
from any Governmental Authority questioning or challenging such
compliance.

(ii) All Benefit Plans that are intended to be qualified under
Section 401(a) of the Code comply in form and in operation with all
applicable requirements of Sections 401(a) and 501(a) of the Code;
there have been no amendments to such Benefit Plans which are not the
subject of a determination letter issued with respect thereto by the
Internal Revenue Service; and no event has occurred that will or could
give rise to disqualification of any such Benefit Plan under such
sections or to any tax under Section 511 of the Code; except that no
representation is made as to the satisfaction of any formal plan
document qualification requirement with respect to which the remedial
amendment period set forth in Section 401(b) of the Code, and any
regulations, writings or other IRS releases thereunder, has not
expired.
<PAGE>

(iii) None of the assets of any Benefit Plan are invested in
employer securities or employer real property, as those terms are
defined in Section 407(d) of ERISA.

(iv) There have been no "prohibited transactions" (as
described in Section 406 of ERISA or Section 4975 of the Code) with
respect to any Benefit Plan and neither the Shareholder, the Company
nor any ERISA Affiliate of the Company has otherwise engaged in any
prohibited transactions.

(v) There have been no acts or omissions by the Shareholder,
the Company or any ERISA Affiliate of the Company that have given rise
to or may give rise to fines, penalties, taxes or related charges
under Sections 502(c), 502(i) or 4071 of ERISA or Chapter 43 of the
Code for which the Company or any ERISA Affiliate of the Company may
be liable.

(vi) There are no actions, suits or claims (other than routine
claims for benefits) pending or threatened involving any Benefit Plans
or the assets of such Plans, and no facts exist which could give rise
to any such actions, suits or claims (other that routine claims for
benefits).

(vii) No Benefit Plan is subject to Title IV of ERISA, or to
the requirements of Section 412 of the Code or Section 402 of ERISA,
and no Benefit Plan is a "multiemployer plan" (within the meaning of
Section 3(37) of ERISA).

(viii) All Benefit Plans that are group health plans have
been operated in compliance with the group health plan continuation
coverage requirements of Section 4980B of the Code and Section 601 of
ERISA to the extent such requirements are applicable, and no such
group health plan is a self-insured plan.

(ix) Actuarially adequate accruals for all obligations or
contingent obligations under the Benefit Plans are reflected in the
Company's Financial Statements provided to the Purchaser and such
obligations include a pro rata amount of the contributions which would
otherwise have been made in accordance with past practices for the
plan years which include the Closing Date.
<PAGE>

(x) The execution and performance of the transactions
contemplated by this Agreement will not, in and of itself, result in
any payment (whether of severance pay or otherwise), acceleration,
vesting, or increase in benefits under any Benefit Plan.

Q. Labor. There have been no material violations of any Federal,
-----
state or local statutes, laws, ordinances, rules, regulations, orders or
directives with respect to the employment of individuals by, or the employment
practices or work conditions of, the Company or any of its subsidiaries, or the
terms and conditions of employment, wages and hours and, to the knowledge of the
Shareholder, no claims of such violations have been asserted. The Company and
its subsidiaries are not engaged in any unfair labor practice or other unlawful
employment practice and there are no charges of unfair labor practices or other
employee-related complaints pending or, to the knowledge of the Shareholder,
threatened against the Company or any of its subsidiaries before the National
Labor Relations Board, the Equal Employment Opportunity Commission, the
Occupational Safety and Health Review Commission, the Department of Labor or any
other Federal, state, local or other Governmental Authority. There is no
strike, picketing, slowdown or work stoppage or organizational attempt pending
or, to the knowledge of the Shareholder, threatened against or involving the
Company or any of its subsidiaries. No issue with respect to union
representation is pending or, to the knowledge of the Shareholder, threatened
with respect to the employees of the Company or any of its subsidiaries. No
union or collective bargaining unit or other labor organization has ever been
certified or recognized by the Company or any of its subsidiaries as the
representative of any of the employees of the Company or any of its
subsidiaries.

R. Compensation. Subsequent to June 30, 1996, there have been no
------------
increases in the compensation payable or to become payable to any of the
employees of the Company or any of its subsidiaries and there have been no
payments or provisions for any awards, bonuses, stock options, loans, profit
sharing, pension, retirement or welfare plans or similar or other disbursements
or arrangements for or on behalf of such employees (or related parties thereof),
in each case, other than in the ordinary course of business or as was required
from time to time by governmental legislation affecting wages. All bonuses
heretofore granted to employees of the Company and its subsidiaries have been
paid in full to such employees.
<PAGE>

S. Insurance. Set forth in the Company Disclosure Schedule is an
---------
accurate and complete list (including the name of the insurer, coverage, premium
and expiration date) of all binders, policies of fire, liability, professional
liability, workers compensation, vehicular, unemployment and other insurance,
self insurance programs and fidelity bonds (collectively, "Insurance")
maintained by or on behalf of the Company and its subsidiaries or in which the
Company and its subsidiaries, or any of them, are named insureds.

T. Restrictions on Business. Neither the Company nor any of its
------------------------
subsidiaries is restricted from conducting the Business as authorized by its
applicable licenses, in any location by agreement or court decree.

U. Patents and Trademarks. Set forth in the Company Disclosure
----------------------
Schedule is a list and brief description of all of the patents, registered and
common law trademarks, service marks, tradenames, copyrights, licenses and other
similar rights of the Company and its subsidiaries and applications for each of
the foregoing. The Company or its subsidiaries, as applicable, owns all right,
title and interest in and to all such proprietary rights. The proprietary rights
listed are all such rights necessary to the conduct of the Business; no adverse
claims have been made and no dispute has arisen with respect to any of such
proprietary rights; and the operation of the Business and the use by the Company
or its subsidiaries of such proprietary rights do not involve infringement or
claimed infringement of any patent, trademark, service mark, tradename,
copyright, license or similar right.

V. Power of Attorney. Neither the Company nor any of its
-----------------
subsidiaries has granted any power of attorney (revocable or irrevocable) to any
person, firm or corporation for any purpose whatsoever.

W. Accounts Payable. The accounts and notes payable and accrued
----------------
expenses are fully and fairly reflected in the Company Financial Statements, and
the accounts and notes payable and accrued expenses incurred by the Company and
its subsidiaries subsequent to June 30, 1996, are in all respects valid claims
that arose in the ordinary course of business. Since June 30, 1996, the
accounts and notes payable and accrued expenses of the Company and its
subsidiaries have been paid on a basis consistent with prior practice.

X. Bank Accounts. Set forth in the Company Disclosure Schedule
-------------
attached hereto is a list of all bank
<PAGE>

accounts of the Company and its subsidiaries, and a list of persons having power
to sign on behalf of the Company and its subsidiaries with respect to each such
account.

Y. Books and Records. The books and records of the Company and its
-----------------
subsidiaries are in all material respects complete and correct, have been
maintained in accordance with good business practices and accurately reflect the
basis for the financial position and results of operations of the Company and
its subsidiaries set forth in the Company Financial Statements. All of such
books and records have been made available for inspection by the Purchaser and
its representatives.

Z. Brokers. Other than Dean Witter Reynolds Inc., no broker, finder
-------
or investment banker is entitled to any brokerage, finder's or other fee or
commission in connection with the transactions contemplated by this Agreement
based upon arrangements made by or on behalf of the Company or the Shareholder.
The Shareholder shall be exclusively liable for all payments owing to Dean
Witter Reynolds Inc. in connection with transactions contemplated by this
Agreement.

AA. Medicare and Medicaid. The Company and each of its subsidiaries
---------------------
have complied in all material respects with all laws, rules and regulations of
the Medicare, Medicaid and other governmental healthcare programs relating to
the Company, any of its subsidiaries or the Business, and have filed all claims,
invoices, returns, cost reports and other forms, the use of which is required or
permitted by such programs, in the manner prescribed. All claims, returns,
invoices, cost reports and other forms filed by the Company or any of its
subsidiaries with Medicare, Medicaid or any other governmental health or
welfare-related entity since the inception of the Company are true, complete,
correct and accurate in all material respects. No deficiency (either
individually or in the aggregate) in any such claims, returns, invoices, cost
reports and other filings, including claims for over-payments or deficiencies
for late filings, has been asserted or, to the knowledge of the Shareholder,
threatened by any federal or state agency or instrumentality or other provider
reimbursement entities relating to Medicare or Medicaid claims or any other
third-party payor, and, to the Shareholder's knowledge, there is no basis for
any claims or requests for reimbursement of the Company or any of its
subsidiaries. Neither the Company nor any of its subsidiaries has been subject
to any audit relating to fraudulent Medicare procedures or practices nor is
there any inquiry or investigation pending or, to the knowledge of the
Shareholder, threatened against the Company
<PAGE>

or any of its subsidiaries with respect to fraudulent Medicare procedures or
practices. There is, to the Shareholder's knowledge, no basis for any claim or
request for recoupment or reimbursement from the Company or any of its
subsidiaries by, or for reimbursement by the Company or any of its subsidiaries
of, any federal or state agency or instrumentality or other provider
reimbursement entities relating to Medicare or Medicaid claims.

BB. Consents. To the Shareholder's knowledge, the Company Disclosure
--------
Schedule sets forth a complete and accurate list of all material approvals,
authorizations, consents, orders or other actions or declarations, filings or
registrations (collectively, "Consents") with, any person, entity, party, court
or Governmental Authority which are required to be made or obtained to permit
(i) the Shareholder to sell the Shares to the Purchaser and to perform the
Shareholder's obligations as provided under this Agreement, (ii) the
Shareholder, the Company and its subsidiaries to execute, deliver and perform
this Agreement and consummate the transactions contemplated hereby, (iii) the
change of ownership of control of the Company and its subsidiaries, and (iv) the
Company and its subsidiaries to have the authority to continue to operate the
Business following the change of control of the Company and its subsidiaries.
To the Shareholder's knowledge, no other material approval, authorization,
consent, order or other action of, or declaration, filing or registration with,
any court or Governmental Authority is required to be made or obtained by or on
behalf of the Shareholder, the Company and the subsidiaries for the Shareholder
to sell the Shares to the Purchaser as contemplated hereunder.

SECTION III
-----------

REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
-----------------------------------------------

The Purchaser hereby represents and warrants to the Shareholder as of
the date hereof that, except as set forth in the Purchaser Disclosure Schedule:

A. Organization; Qualification. The Purchaser is duly organized,
---------------------------
validly existing and in good standing under the laws of its state of
incorporation and has full corporate power and authority to own its properties
and to conduct the businesses in which it is now engaged. The Purchaser is in
good standing in each other jurisdiction where it is presently conducting
business wherein the failure so to qualify would have a material adverse effect
<PAGE>

on the business or properties of the Purchaser. The Purchaser has full power,
authority and legal right and all necessary consents, approvals, permits,
licenses and authorizations to own its properties and to conduct its businesses.
Complete and correct copies of the certificate of incorporation and by-laws of
the Purchaser have been delivered to the Shareholder.

B. Due Authorization. The execution and delivery of this Agreement
-----------------
by the Purchaser, the performance by the Purchaser of its covenants and
agreements hereunder and the consummation by the Purchaser of the transactions
contemplated hereby have been duly authorized by all necessary corporate action,
and this Agreement constitutes the valid and legally binding obligation of the
Purchaser, enforceable against the Purchaser in accordance with its terms,
except as enforceability may be limited by bankruptcy, insolvency,
reorganization or other similar laws affecting creditors' rights generally or by
general principles of equity.

C. No Conflicts. Neither the execution and delivery of this
------------
Agreement, nor the consummation of the transactions contemplated hereby,
violates any provision of the certificate of incorporation or by-laws of the
Purchaser or, subject to receipt of the necessary governmental and regulatory
approvals as set forth in Schedule II(BB) of the Company Disclosure Schedule,
any statute, ordinance, regulation, order, judgment or decree of any court or
Governmental Authority, or conflicts with or will result in any breach of any of
the terms of or constitute a default under or result in the termination of or
the creation of any lien pursuant to the terms of any contract or agreement to
which the Purchaser is a party or by which the Purchaser or any of its assets is
bound.

D. Investment. (i) The Purchaser understands that the Shareholder
----------
proposes to deliver to the Purchaser the Shares without compliance with the
registration requirements of the Securities Act; that for such purpose the
Shareholder will rely upon the representations, warranties, covenants and
agreements contained herein; and that such non-compliance with registration is
not permissible unless such representations and warranties are correct and such
covenants and agreements performed.

(ii) The Shareholder understands that, under existing rules of the
Securities and Exchange Commission, the Purchaser may be unable to sell any of
the Shares except to the extent that such Shares may be sold (i) pursuant to an
effective registration statement covering such shares
<PAGE>

pursuant to the Securities Act or (ii) in a bona fide private placement to a
purchaser who shall be subject to the same restrictions on any resale. The
Purchaser understands that the Shareholder is not under any obligation to effect
a registration of any of the Shares under the Securities Act.

(iii) The Purchaser is a sophisticated investor familiar with the
type of risks inherent in the acquisition of restricted securities such as the
Shares and the Purchaser's financial position is such that it can afford to
retain its Shares for an indefinite period of time without realizing any direct
or indirect cash return on its investment.

(iv) The Purchaser is acquiring the Shares for its own account and not
with a view to, or for sale in connection with, the distribution thereof within
the meaning of the Securities Act.

E. Funds. The Purchaser has adequate resources available to pay the
-----
Purchase Price at the Closing as provided by Section I(B).
SECTION IV
----------

ADDITIONAL REPRESENTATIONS AND
WARRANTIES OF THE SHAREHOLDER
------------------------------

The Shareholder hereby represents and warrants to the Purchaser as of
the date hereof that, except as set forth in the Shareholder Disclosure
Schedule:

A. Organization; Qualification. The Shareholder is a corporation
---------------------------
duly organized, validly existing and in good standing under the laws of the
State of Delaware and has full corporate power and authority to own its
properties and to conduct the businesses in which it is now engaged. The
Shareholder is in good standing in each other jurisdiction where it is presently
conducting business wherein the failure so to qualify would have a material
adverse effect on the business or properties of the Shareholder.

B. Due Authorization. The execution and delivery of this Agreement
-----------------
by the Shareholder, the performance by the Shareholder of its covenants and
agreements hereunder and the consummation by the Shareholder of the transactions
contemplated hereby have been duly authorized by all necessary corporate action,
and this Agreement constitutes a valid and legally binding obligation
<PAGE>

of the Shareholder, enforceable against the Shareholder in accordance with its
terms.

C. No Conflicts. Neither the execution and delivery of this
------------
Agreement, nor the consummation of the transactions contemplated hereby,
violates the certificate of incorporation or by-laws of the Shareholder or,
subject to the receipt of the necessary governmental and regulatory approvals as
set forth in Schedule II(BB) of the Company Disclosure Schedule, any statute,
ordinance, regulation, order, judgment or decree of any court or Governmental
Authority applicable to the Shareholder, or conflicts with or will result in any
breach of any of the terms of or constitute a default under or result in the
termination of or the creation of any lien pursuant to the terms of any contract
or agreement to which the Shareholder is a party or by which the Shareholder or
any of the assets of the Shareholder is bound.

D. Ownership of Shares, etc. The Shareholder owns and has good and
-------------------------
marketable title to the Shares, which Shares represent all of the issued and
outstanding shares of capital stock of the Company, free and clear of any lien,
encumbrance, charge, security interest or claim whatsoever (including any
restriction on the right to vote, sell or otherwise dispose of the Shares), and
the Shareholder has the right to transfer the Shares to the Purchaser and, upon
transfer of the Shares to the Purchaser hereunder, the Purchaser will acquire
good and marketable title to the Shares, free and clear of any lien,
encumbrance, charge, security interest or claim whatsoever.

SECTION V
---------

COVENANTS OF THE COMPANY
------------------------

A. Negative Covenants. The Company hereby covenants and agrees with
------------------
the Purchaser that, except as hereafter consented to in writing by the Purchaser
or as otherwise set forth in the Company Disclosure Schedule, from and after the
date of this Agreement and until the Closing, the Company shall not (and shall
cause each of its subsidiaries not to):

(i) Make a purchase, sale or lease in respect of the Business, or
introduce any method of management, accounting or operation in respect of the
Business, except in the ordinary course of business which in any event does not
involve the potential payment to or by
<PAGE>

the Company or any of its subsidiaries in one or more installments of an amount
greater than $5,000.

(ii) Fail to maintain, repair, service or preserve, or in any way
further encumber, its properties, other than inventory sold or used, accounts
receivable collected upon and supplies used, in each case in the ordinary course
of business, after the date hereof, for which, in the case of inventory and
supplies, replacements have been made consistent with prior practice.

(iii) Make loans or advances or grant pay raises, bonuses or
awards, directly or indirectly, (a) to any officer or director of the Company or
any of its subsidiaries or (b) except as required under existing employee
agreements, to any other employee of the Company.

(iv) Declare or pay any dividend or make any other distribution in
respect of the capital stock of the Company, or, directly or indirectly,
purchase, redeem or otherwise acquire or dispose of any shares of the capital
stock of the Company or, except in the ordinary course of business (which in any
event does not involve the payment by the Company of an amount greater than
$5,000), pay or discharge any outstanding indebtedness.

(v) Fail to use its reasonable best efforts to (a) preserve the
present business organization of the Company and its subsidiaries intact; (b)
keep available the services of the present employees of the Company and its
subsidiaries; and (c) preserve present relationships with entities or persons
having business dealings with the Company and its subsidiaries.

(vi) Fail to maintain the books and records of the Company and its
subsidiaries in accordance with good business practices, on a basis consistent
with prior practice.

(vii) Fail to use its reasonable best efforts to comply in all
material respects with all statutes, ordinances, regulations, orders, judgments
and decrees of every court or Governmental Authority applicable to the Company
and its subsidiaries and to the conduct of the Business and perform all of its
obligations with respect thereto without default.

(viii) Fail to maintain and pay all premiums with respect to such
policies of insurance as are currently held in the name of the Company or any of
its subsidiaries.
<PAGE>

(ix) Make any change materially adverse to the Company or any of its
subsidiaries in the terms of any Contract or fail to perform any of its
obligations with respect thereto without default.

(x) Enter into any contract, lease or other commitment, written or
oral, which in any event involves the potential payment to or by the Company or
any of its subsidiaries in one or more installments of an amount greater than
$5,000, without obtaining the consent of Purchaser, which consent shall not be
unreasonably withheld or delayed.

(xi) Fail to furnish to the Purchaser, its counsel, accountants and
authorized representatives, such financial, legal and other documents, records
and information relating to the Company and its subsidiaries and the properties
of the Company and its subsidiaries as the Purchaser, its counsel, accountants
and its authorized representatives may from time to time reasonably request.

(xii) Fail to file any tax returns required to be filed by or with
respect to the Company or any of its subsidiaries, fail to pay any taxes that
become due, payable or otherwise owing by the Company or any of its
subsidiaries, or pay or determine any taxes pertaining to the Company or any of
its subsidiaries other than in accordance with the past practices of both the
Shareholder and the Company or other than in the ordinary course of business.

(xiii) Fail to make available to the Purchaser the books of account,
records, tax returns, leases, contracts and other documents or agreements
material to the Business as the Purchaser, its counsel, accountants and its
authorized representatives may from time to time reasonably request.

(xiv) Fail to cooperate fully with the Purchaser, do all things
reasonably necessary to assist the Purchaser and use its reasonable best efforts
at its own expense to obtain all consents and approvals necessary for the
transfer of the Shares, including the furnishing of all financial and other
information reasonably required by the party whose consent or approval is being
sought.

(xv) Issue any shares of Common Stock.

(xvi) Make any amendment to the Company's Certificate of
Incorporation or by-laws.
<PAGE>

(xvii) Agree to do any of the above.

SECTION VI
----------

COVENANTS OF THE PURCHASER
--------------------------

A. General. The Purchaser hereby covenants and agrees with the
-------
Shareholder that, except as hereafter consented to in writing by the
Shareholder, from and after the date of this Agreement and until the Closing,
the Purchaser shall not:

(i) Fail to furnish to the Shareholder, its counsel, accountants and
authorized representatives, such financial, legal and other documents, records
and information relating to the organization and financial condition of the
Purchaser and availability of cash for the payment of the Purchase Price by the
Purchaser as the Shareholder, its counsel, accountants and its authorized
representatives may from time to time reasonably request.

(ii) Fail to cooperate fully with the Shareholder and do all things
reasonably necessary to assist the Shareholder and use its reasonable best
efforts at its own expense to obtain all consents and approvals necessary for
the transfer of the Shares, including the furnishing of all financial and other
information reasonably required by the party whose consent or approval is being
sought. Such approvals include approval of the respective DOI in each of
Alabama, Louisiana and Mississippi.

B. Employees. As of the Closing Date, the Company and each
---------
Subsidiary shall retain in their employment all those persons employed by the
Company or such Subsidiary as of the Closing Date (the "Employees"), and the
Purchaser shall cause the Company and each Subsidiary to retain, for a period of
ninety (90) days following the Closing Date, such number of the Employees as
shall be necessary to avoid any potential liability by any party for a violation
of the Workers Adjustment Retraining and Notification Act (the "Warn Act")
attendant to a failure to notify such Employees of a "mass layoff" or "plant
closing" as defined in the Warn Act. As of the Closing Date, the Purchaser
agrees, in accordance with Section XI hereof, to indemnify and hold the
Shareholder and each of its affiliates harmless from and against any
Shareholder's Damages (as defined in Section XI(D) hereof) asserted against or
suffered by the Shareholder or any of its affiliates under the Warn Act arising
out of or resulting from the failure to comply with the provisions of the Warn
Act as of or after the Closing
<PAGE>

Date. Nothing herein shall be deemed to create or to grant to the Employees any
third party beneficiary rights or claims or causes of action of any kind or
nature.

SECTION VII
-----------

ADDITIONAL AGREEMENTS
---------------------

A. Appropriate Action; Consents; Filings. (a) The Shareholder, the
-------------------------------------
Company and the Purchaser shall use reasonable best efforts to (i) take, or
cause to be taken, all appropriate action, and do, or cause to be done, all
things necessary under applicable law or otherwise to consummate and make
effective the transactions contemplated by this Agreement as promptly as
practicable, (ii) obtain from any Governmental Authority any consents, licenses,
permits, waivers, approvals, authorizations or orders required to be obtained or
made by the Purchaser or the Company or any of its subsidiaries in connection
with the authorization, execution and delivery of this Agreement and the
consummation of the transactions contemplated in this Agreement, (iii) make all
necessary notifications and filings, and thereafter make any other required
submissions and attend hearings, with respect to this Agreement and the
transactions contemplated hereby required under (A) the HMO Acts and (B) any
other applicable law, (iv) obtain a complete and unconditional release from
liability of, or consent to assignment by, the Shareholder and/or Ramsay Health
Care, Inc. ("RHCI"), as applicable, under the Lease dated October 6, 1995
between the Shareholder and American Business Credit Corporation ("ABC"), the
Lease dated October 30, 1995 between the Shareholder and ABC, and the Lease
dated March 24, 1995, as supplemented, between RHCI and IBM Credit Corporation
(collectively, the "Affiliate Leases"), without any payment by the Shareholder
or RHCI and (v) at the expense of the Shareholder, cause (x) the sublease
between RHCI and the Company relating to the New Orleans office of the Company
to be terminated effective as of the Closing Date, and (y) the lease between the
Company and Tom Williams Auto, Inc. relating to a Lexus automobile to be
terminated or transferred out of the Company effective on or before the Closing
Date (the sublease and lease referred to in clauses (x) and (y) being referred
to hereinafter as the "Excluded Contracts"; provided that, the Shareholder, the
Purchaser and the Company shall cooperate with each other in connection with the
making of all such filings, including providing copies of all such documents to
the non-filing party and its advisors prior to filing and, if requested, to
accept all reasonable additions, deletions or changes suggested in connection
therewith. The
<PAGE>

Shareholder, the Company and the Purchaser shall furnish to each other all
information required for any application or other filing to be made pursuant to
the rules and regulations of any applicable law in connection with the
transactions contemplated by this Agreement. Without in any way limiting the
foregoing, the Purchaser shall make all necessary notifications and filings,
complete in all respects, with the applicable DOI and any other Governmental
Authority, as promptly as practicable and in any event within fifteen (15)
business days following execution of this Agreement.

(b) (i) The Company and its subsidiaries and the Purchaser shall
give any notices to third parties, and use all reasonable efforts to obtain any
third party consents necessary to consummate the transactions contemplated in
this Agreement including those consents required to be disclosed in the Company
Disclosure Schedule or the Purchaser Disclosure Schedule, as the case may be.

(ii) In the event that either party shall fail to obtain any third
party consent described in subsection (b)(i) above, such party shall use all
reasonable efforts, and shall take any such actions reasonably requested by the
other party, to minimize any adverse effect upon the Shareholder, the Company
and the Purchaser, their respective subsidiaries, and their respective
businesses resulting, or which could reasonably be expected to result after the
Closing, from the failure to obtain such consent.

(c) From the date of this Agreement until the Closing, the Shareholder
or the Company shall promptly notify the Purchaser in writing of any pending or,
to the knowledge of the Shareholder, threatened, action, proceeding or
investigation by any Governmental Authority or any other person seeking to
restrain or prohibit the consummation of the transactions contemplated by this
Agreement or otherwise limit the right of the Purchaser to own or operate all or
any portion of the business or assets of the Company or its subsidiaries.

(d) From the date of this Agreement until the Closing, the Purchaser
shall promptly notify the Shareholder in writing of any pending or, to the
knowledge of the Purchaser, threatened action, proceeding or investigation by
any Governmental Authority or any other person seeking to restrain or prohibit
the consummation of the transactions contemplated by this Agreement or otherwise
limit the right of the Purchaser to own or operate all or any portion of the
business or assets of the Company or its subsidiaries.
<PAGE>

B. Tax Matters. (i) All transfer, documentary, sales, use, stamp,
-----------
registration, value added and other such taxes and fees (including any penalties
and interest, but specifically excluding any effect on the income taxes payable
by the Shareholder as a result of the sale of the Shares) (collectively,
"Transfer Taxes") incurred in connection with this Agreement shall be borne and
paid for equally by the Shareholder and the Purchaser when due, and the
Shareholder will, at its own expense, file all necessary tax returns and other
documentation with respect to all Transfer Taxes and fees, and, if required by
applicable law, the Purchaser will join in the execution of any such tax returns
and other documentation.

(ii) The Shareholder shall be responsible for the preparation and
filing of its consolidated federal income tax return for the taxable year that
includes the Closing Date, including the Company and its subsidiaries on a
consolidated basis for the period that ends at the close of the Closing Date,
and shall be responsible for the federal income taxes payable by or on behalf of
the Company and its subsidiaries for all periods to the Closing Date. The
Purchaser shall be responsible for the preparation and filing of all tax returns
of the Company and its subsidiaries for periods ending after the Closing Date,
and shall be responsible for the taxes payable by or on behalf of the Company
and its subsidiaries for all such periods.

C. Employment Agreements. At or prior to the Closing, if requested by
---------------------
the Purchaser, the Shareholder shall cause the employment agreements listed in
Schedule II(O) (1 through 3) of the Company Disclosure Schedule to be
terminated. The Shareholder shall indemnify and hold harmless the Purchaser and
the Company from and against any and all Damages (as hereinafter defined)
arising out of or relating to such employment agreements, including obligations
for salary continuation, severance pay, bonus and benefits continuation under
COBRA upon any termination of employment under any such employment agreement.
The obligations of the Shareholder under this Section VII(C) shall survive the
Closing. The Shareholder shall cause the Company to enter into such employment
agreements, if any, as shall be mutually agreed to by the Purchaser and the
respective employee prior to the Closing.

D. Affiliate Leases. In the event an unconditional release from
----------------
liability of the Shareholder and/or RHCI, as applicable, is not obtained with
respect to any Affiliate Lease, the Purchaser and the Company, jointly
<PAGE>

and severally, shall indemnify and hold harmless the Shareholder and RHCI from
and against any and all Damages arising out of or relating to such Affiliate
Lease arising on or after the Closing Date. The obligations of the parties
under this Section VII(D) shall survive the Closing and continue in effect until
thirty (30) days following expiration of the applicable statute of limitations
period for claims under such Affiliate Lease.

SECTION VIII
------------

CLOSING
-------

A. Time and Place of Closing. The closing of the purchase and sale
-------------------------
of the Shares as set forth herein (the "Closing") shall be held at the office of
Haythe & Curley at 237 Park Avenue, New York, New York within two (2) business
days of the date on which all of the conditions set forth herein to each party's
obligations hereunder have been satisfied or waived (the "Closing Date").
Either party may elect to conduct the Closing by mail, fax and wire.

B. Delivery of Shares. Delivery of the Shares shall be made by the
------------------
Shareholder to the Purchaser at the Closing by delivering one or more
certificates in negotiable form representing the Shares, each such certificate
to be accompanied by any requisite documentary or stock transfer taxes.

SECTION IX
----------

CONDITIONS TO THE OBLIGATIONS OF THE SHAREHOLDER
------------------------------------------------

The obligations of the Shareholder to consummate the transactions
contemplated by this Agreement at the Closing shall be subject to the following
conditions precedent, any or all of which may be waived by the Shareholder in
its sole discretion, and each of which the Purchaser hereby agrees to use its
reasonable best efforts to satisfy at or prior to the Closing:

(i) Accuracy of Representations and Warranties. The representations
------------------------------------------
and warranties made by the Purchaser herein shall be true and correct as of the
Closing Date in all material respects with the same force and effect as though
such representations and warranties had been made as of the Closing Date;
provided, however, that those representations and warranties which address
matters only as of a particular date shall remain true and correct as of
<PAGE>

such date. On the Closing Date, the Purchaser shall deliver to the Shareholder
a certificate of its chief executive officer dated the Closing Date to such
effect. The Purchaser shall have duly complied with and performed in all
material respects all of its obligations under this Agreement to be complied
with and performed on or before the Closing Date.

(ii) Certificate of Secretary. The Shareholder shall have received
------------------------
certificates of the Secretary or Assistant Secretary of the Purchaser certifying
(a) that attached thereto is a true and complete copy of the resolutions adopted
by the Board of Directors of the Purchaser authorizing the execution, delivery
and performance of this Agreement, and the consummation of the transactions
contemplated hereby, and (b) as to the incumbency and genuineness of the
signature of each officer of the Purchaser executing this Agreement and any
other documents delivered in connection herewith.

(iii) Good Standing Certificates. The Shareholder shall have
--------------------------
received a good standing certificate for the Purchaser, issued by the Secretary
of State or other appropriate official of its state of incorporation.

(iv) Opinion of Counsel. The Shareholder shall have received an
------------------
opinion of Winderweedle, Haines, Ward & Woodman, P.A., counsel to the Purchaser,
delivered to the Shareholder pursuant to the instructions of the Purchaser,
dated the Effective Date, covering the matters set forth in Exhibit B attached
hereto.

SECTION X
---------

CONDITIONS TO THE OBLIGATIONS OF THE PURCHASER
----------------------------------------------

The obligations of the Purchaser to consummate the transactions
contemplated by this Agreement at the Closing shall be subject to the following
conditions precedent, any or all of which may be waived by the Purchaser in its
sole discretion, and each of which the Company and the Shareholder hereby agree
to use their respective reasonable best efforts to satisfy at or prior to the
Closing:

(i) Accuracy of Representations and Warranties. The representations
------------------------------------------
and warranties made by the Shareholder herein shall be true and correct as of
the Closing Date in all material respects with the same force and effect as
though such representations and warranties had been made as of the Closing Date;
provided, however, that
<PAGE>

those representations and warranties which address matters only as of a
particular date shall remain true and correct as of such date. On the Closing
Date, the Shareholder shall deliver to the Purchaser a certificate of its Chief
Executive Officer dated the Closing Date to such effect. The Shareholder and
the Company shall have complied with and performed in all material respects all
of its obligations under this Agreement to be complied with and performed on or
before the Closing Date.

(ii) Certificate of Secretary. The Purchaser shall have received a
------------------------
certificate of the Secretary or Assistant Secretary of the Shareholder
certifying (a) that attached thereto is a true and complete copy of the
resolutions adopted by the Board of Directors of the Shareholder authorizing the
execution, delivery and performance of this Agreement and the consummation of
the transactions contemplated hereby, and (b) as to the incumbency and
genuineness of the signature of each officer of the Shareholder executing this
Agreement and any documents delivered in connection herewith.

(iii) Good Standing Certificates. The Purchaser shall have
--------------------------
received good standing certificates for the Shareholder, the Company and each of
the Company's subsidiaries, issued by the Secretary of State or other
appropriate official of their respective states of incorporation.

(iv) Opinion of Counsel. The Purchaser shall have received an opinion
------------------
of Haythe & Curley, counsel for the Shareholder and the Company, and, at the
Shareholder's option, one or more local counsel, delivered to the Purchaser
pursuant to the instructions of the Shareholder and the Company, dated the
Closing Date, covering the matters set forth in Exhibit C attached hereto.

(v) Resignations. The Company shall have delivered to the Purchaser
------------
resignations of all of the directors of the Company and each of its
subsidiaries, such resignations to be effective as of the Closing.

(vi) Release. As of the Closing, the Shareholder shall have delivered
-------
a release and discharge of the Company and its subsidiaries from any and all
claims or liabilities which the Shareholder has or may have against the Company
or its subsidiaries, other than any claims or liabilities arising under this
Agreement.

(vii) Performance. The Shareholder, the Company and the
-----------
subsidiaries, as the case may be, shall have
<PAGE>

performed and complied in all material respects with all covenants and
agreements required by this Agreement to be performed or complied with by each
of them prior to or at the Closing.

(viii) Regulatory Actions. There shall be no regulatory action
------------------
threatened or pending which has a material likelihood of resulting in suspension
or revocation of any material license or permit held by the Company or its
subsidiaries.

(ix) Approval and Consents. The Shareholder and the Company and its
---------------------
subsidiaries shall have obtained the applicable DOI's and any applicable
Governmental Authority's approval and/or consent under the applicable HMO Act
and any other applicable law or regulations, of the sale of Shares to the
Purchaser as provided under this Agreement. All other material permits,
approvals, consents or authoriza-tions of any Governmental Authority necessary
for the consummation of the transactions contemplated by this Agreement shall
have been obtained by the appropriate party. Any other material consent or
other approval to the transactions contemplated by this Agreement which the
Purchaser, the Shareholder and the Company and its subsidiaries are required to
obtain shall have been obtained and any necessary consent under any Contract
shall have been obtained in writing. In the event that the necessary consents
of each applicable DOI shall not have been obtained within three (3) months from
the date on which Purchaser's notifications and filings, complete in all
respects, shall have been made with the applicable DOI, then this Agreement may
be extended by not more than fifteen (15) business days thereafter by either
party by written notice to the other party in order to obtain such consent. If
such consent shall not be received by the end of such fifteen (15) business day
period, either party (unless the failure to obtain such consent is attributable
to a default under this Agreement by such party) shall have the unilateral and
unequivocal right to terminate all prospective obligations under this Agreement.

(x) No Changes in the Business of the Company and the subsidiaries.
--------------------------------------------------------------
The Company and its subsidiaries shall have been operated in accordance with
past practice and not in violation of Section V of this Agreement and there
shall have not otherwise occurred any material adverse change in the operations,
operating results, business, or condition (financial or otherwise) of the
Company and its subsidiaries, the respective assets or the Shares from the date
hereof until the Closing Date, it being understood that changes resulting from
continuing losses in the normal cause of business consistent with prior
<PAGE>

operating results shall not be deemed a material adverse change.

(xi) Subsidiary Shares. At the Closing, the Shareholder shall cause
-----------------
the holders of shares of capital stock of any subsidiary of the Company not
owned by the Company to transfer such shares to such person or persons as shall
be designated by the Purchaser.

SECTION XI
----------

INDEMNIFICATION
---------------

A. Indemnification by the Shareholder. The Shareholder shall
----------------------------------
indemnify and hold harmless the Purchaser and the Company from and against any
and all losses, claims, assessments, demands, damages, liabilities, obligations,
costs and/or expenses whatsoever (hereinafter referred to collectively as the
"Purchaser's Damages"), including, without limitation, Purchaser's Counsel
Expenses (as hereinafter defined), sustained or incurred by the Purchaser or the
Company as a result of or arising from (i) the breach of any of the obligations,
covenants or provisions of, or the inaccuracy of any of the representations or
warranties made by, the Shareholder or the Company herein, (ii) the litigation
referred to in Schedule II (I) of the Company Disclosure Schedule and (iii) any
Excluded Contract. For purposes hereof "Purchaser's Counsel Expenses" shall
mean reasonable fees and disbursements of counsel howsoever sustained or
incurred by the Purchaser or the Company, including, without limitation, in any
action or proceeding between the Purchaser or the Company (on the one hand) and
the Shareholder (on the other hand) or in any action or proceeding between the
Purchaser or the Company and any third party.

B. Indemnification by the Purchaser. The Purchaser shall indemnify
--------------------------------
and hold harmless the Shareholder from and against any and all losses, claims,
assessments, demands, damages, liabilities, obligations, costs and/or expenses
whatsoever (hereinafter referred to as the "Shareholder's Damages"; the
Shareholder's Damages and the Purchaser's Damages are sometimes referred to
herein as the "Damages"), including, without limitation, Shareholder's Counsel
Expenses (as hereinafter defined), sustained or incurred by the Shareholder as a
result of or arising from the breach of any of the obligations, covenants or
provisions of, or the inaccuracy of any of the representations or warranties
made by, the Purchaser herein. For purposes hereof "Shareholder's Counsel
Expenses" shall
<PAGE>

mean reasonable fees and disbursements of counsel howsoever sustained or
incurred by the Shareholder, including, without limitation, in any action or
proceeding between the Shareholder (on the one hand) and the Purchaser or the
Company (on the other hand) or in any action or proceeding between the
Shareholder and any third party.

C. Procedure for Indemnification. In the event that any party hereto
-----------------------------
shall incur (or reasonably anticipate that it may incur in the case of third
party claims) any Damages in respect of which indemnity may be sought by such
party pursuant to this Section XI or any other provision of this Agreement, the
party indemnified hereunder (the "Indemnitee") shall notify the party providing
indemnification (the "Indemnitor") promptly; provided, however, that any delay
or failure to notify any Indemnitor of any claim shall not relieve it from any
liability except to the extent that the Indemnitor demonstrates that the defense
of such action is prejudiced by such delay or failure to notify. No claim for
indemnification shall be made by the Indemnitee unless and until the aggregate
Damages for all claims for indemnification then or previously made by the
Indemnitee shall have exceeded $5,000, at which time the Indemnitee shall be
entitled to indemnification for all Damages, without regard to such $5,000
threshold. In the case of third party claims, the Indemnitor shall, within 15
days of receipt of notice of such claim, notify the Indemnitee of its intention
to assume the defense of such claim. If the Indemnitor shall assume the defense
of the claim, the Indemnitor shall have the right and obligation (i) to conduct
any proceedings or negotiations in connection therewith and necessary or
appropriate to defend the Indemnitee, (ii) to take all other required steps or
proceedings to settle or defend any such claims and (iii) to employ counsel to
contest any such claim or liability in the name of the Indemnitee or otherwise.
If defendants in any action include the Indemnitee and the Indemnitor, and the
Indemnitee shall have been advised by its counsel that there may be legal
defenses available to the Indemnitee which are different from or in addition to
those available to the Indemnitor, the Indemnitee shall have the right to employ
its own counsel in such action, and, in such event, the fees and expenses of
such counsel shall be borne by the Indemnitor. If the Indemnitor shall not
assume the defense of any such claim or litigation resulting therefrom, the
Indemnitee may defend against any such claim or litigation in an appropriate
manner; provided, however, that the Indemnitee may not settle any such claim or
-------- -------
litigation without the prior written consent of the Indemnitor, which may not be
unreasonably withheld if the Indemnitor receives a full release as a part of
such
<PAGE>

settlement. Payment of Damages shall be made within 10 days of a final
determination of a claim.

A final determination of a disputed claim shall be (i) a judgment of
any court determining the validity of a disputed claim, if no appeal is pending
from such judgment or if the time to appeal therefrom has elapsed, (ii) an award
of any arbitration determining the validity of such disputed claim, if there is
not pending any motion to set aside such award or if the time within which to
move to set such award aside has elapsed, (iii) a written termination of the
dispute with respect to such claim signed by all of the parties thereto or their
attorneys, (iv) a written acknowledgement of the Indemnitor that it no longer
disputes the validity of such claim, or (v) such other evidence of final
determination of a disputed claim as shall be reasonably acceptable to the
parties.

It is understood and agreed that the Shareholder shall have complete
authority and responsibility for the conduct of the litigation described in
Schedule II(I) of the Company Disclosure Schedule, that the Shareholder shall
conduct such litigation at the Shareholder's sole cost and expense and that the
Shareholder hereby assumes the defense of any claim asserted against the
Purchaser, the Company or any of its subsidiaries in connection therewith. Any
recovery in such litigation by way of damages, settlement or otherwise by the
Shareholder, the Company or any of its subsidiaries shall be paid over
immediately to the Shareholder and shall belong to the Shareholder.

D. Limitation on Indemnification. The aggregate liability of the
-----------------------------
Shareholder for breaches of the representations, warranties, covenants and
agreements of the Shareholder and the Company in this Agreement and the
aggregate liability of the Purchaser for breaches of its representations,
warranties, covenants and agreements in this Agreement shall in each case be
limited to the amount of the Purchase Price.

E. Subrogation. The Shareholder shall be subrogated to all rights of
-----------
the Purchaser or the Company with respect to any claim for which the Purchaser
or the Company has been indemnified by the Shareholder hereunder, provided,
that, the Purchaser shall not be required to make any claim against the Company
or any other party in order to pursue any claim against the Shareholder and
provided further, that the Shareholder shall not be entitled to any
indemnification or right of contribution from the Company or have any other
rights against the Company in connection with any claim made hereunder.
<PAGE>

SECTION XII
-----------

MISCELLANEOUS
-------------

A. Notices. All notices, requests or instructions hereunder shall be
-------
in writing and delivered personally, by recognized overnight courier or by
registered or certified mail, postage prepaid, return receipt requested, as
follows:

(1) If to the Shareholder (or before the Closing, the Company):

Ramsay Managed Care, Inc.
One Poydras Plaza
639 Loyola Avenue
Suite 1725
New Orleans, Louisiana 70113
Attention: Mr. Warwick D. Syphers
Executive Vice President

with a copy to:

Thomas M. Haythe, Esq.
Haythe & Curley
237 Park Avenue
New York, New York 10017

(2) If to the Purchaser (or after the
Closing, the Company):

RoTech Medical Corporation
4506 L.B. McLeod Road
Suite F
Orlando, Florida 32811
Attention: Stephen R. Griggs
President

with a copy to:

Thomas A. Simser, Esq.
Winderweedle, Haines, Ward &
Woodman, P.A.
P.O. Box 1391
Orlando, Florida 32802-1391

Any of the above addresses may be changed at any time by notice given as
provided above; provided, however, that any such notice of change of address
shall be effective only upon receipt. All notices, requests or instructions
given in accordance herewith shall be deemed received on the date
<PAGE>

of delivery, if hand delivered or sent by recognized overnight courier, and
three business days after the date of mailing, if mailed.

B. Survival of Representations. Each representation and warranty of
---------------------------
the parties hereto herein contained shall survive the Closing until the
expiration of a period of six (6) months from the Closing Date, regardless of
any investigation which may have been made by or on behalf of the Purchaser; and
provided further that nothing in the foregoing shall be deemed to diminish any
Indemnitor's indemnification obligations to an Indemnitee respecting any claim
for Damages under Section XI hereof for which notice to the Indemnitor has been
given pursuant to Section XI hereof prior to the end of such applicable period.

C. Entire Agreement; Modifications. This Agreement and the
-------------------------------
documents referred to herein contain the entire agreement among the parties
hereto with respect to the transactions contemplated hereby; this Agreement
shall only become binding and effective upon execution and delivery hereof by
all of the parties hereto, and no modification hereof shall be effective unless
in writing and signed by the party against which it is sought to be enforced.

D. Reasonable Best Efforts. Each of the parties hereto shall use
-----------------------
such party's reasonable best efforts to take such actions as may be necessary or
reasonably requested by the other parties hereto to carry out and consummate the
transactions contemplated by this Agreement.

E. Expenses. Each of the parties hereto shall bear its own expenses
--------
in connection with this Agreement and the transactions contemplated hereby.

F. Enforceability. Should any provision of this Agreement be held
--------------
by a court or arbitration panel of competent jurisdiction to be enforceable only
if modified, such holding shall not affect the validity of the remainder of this
Agreement, the balance of which shall continue to be binding upon the parties
hereto with any such modification to become a part hereof and treated as though
originally set forth in this Agreement. The parties further agree that any such
court or arbitration panel is expressly authorized to modify any such
unenforceable provision of this Agreement in lieu of severing such unenforceable
provision from this Agreement in its entirety, whether by rewriting the
offending provision, deleting any or all of the offending provision, adding
additional language to this Agreement, or
<PAGE>

by making such other modifications as it deems warranted to carry out the intent
and agreement of the parties as embodied herein to the maximum extent permitted
by law. The parties expressly agree that this Agreement as modified by the
court or arbitration panel shall be binding upon and enforceable against each of
them. In any event, should one or more of the provisions of this Agreement be
held to be invalid, illegal or unenforceable in any respect, such invalidity,
illegality or unenforceability shall not affect any other provisions hereof, and
if such provision or provisions are not modified as provided above, this
Agreement shall be construed as if such invalid, illegal or unenforceable
provisions had never been set forth herein.

G. Termination.
-----------

(i) Either party may terminate this Agreement in the event of a
material breach by the other party. The non-breaching party shall give the
breaching party written notice of the material breach. If the breaching party
does not cure the breach within ten (10) days after receipt of the written
notice of breach, the non-breaching party may terminate this Agreement by
sending written notice to the breaching party, which notice shall be effective
on the date given. The notice of termination must be sent within three (3) days
after the cure period has ended.

(ii) Either party may terminate this Agreement upon five (5) days'
written notice to the other party in the event of the liquidation or bankruptcy
or similar proceeding of such other party or upon any sequestration by any
Governmental Authority of all of the assets of such other party.

(iii) This Agreement may be terminated in whole or in part at any
time by the mutual written agreement of the parties.

(v) In the case of a termination of this Agreement pursuant to clauses
(i) or (ii) of this Section XII(G), such termination shall be without prejudice
to any remedies which any party may have under applicable law for breach of
contract.

H. Definitions. The following capitalized terms used throughout this
-----------
Agreement shall have the meaning set forth respectively after each such term.

(a) DOI. Department of Insurance for the States of Alabama,
---
Louisiana or Mississippi.
<PAGE>

(b) Governmental Authority. The federal government, any state,
----------------------
county, municipal, local or foreign government and any governmental agency,
bureau, commission, authority or body having jurisdiction over the Company's or
any subsidiary's business.

(c) HMO Acts. The Mississippi Health Maintenance Organization,
--------
Preferred Provider Organization and other Prepaid Health Benefit Plans
Protection Act, 1995 Miss. Laws Ch. 613 (S.B. 2669); the Louisiana Health
Maintenance Organization Act, La. St. 22:2001 et seq., and relevant Louisiana
Insurance Code provisions; Alabama Statutes Title 27, Chapter 21A; relevant
provisions of the insurance codes or similar statutes in the States of Alabama,
Louisiana and Mississippi; applicable health welfare and/or health care laws in
the States of Alabama, Louisiana and Mississippi; and the rules and regulations
promulgated thereunder by the respective Governmental Authorities, including
DOI, as amended from time to time.

I. Survival of Covenants and Agreements. Except as expressly
------------------------------------
provided in this Agreement, all covenants and agreements made hereunder or
pursuant hereto or in connection with the transactions contemplated hereby shall
not terminate but shall survive the Closing and be enforceable until [six (6)]
months after the Closing Date, at which time they shall expire.

J. Return of Documentation. Following a termination in accordance
-----------------------
with Section XII(G), the Purchaser shall return all agreements, documents,
contracts, instruments and other books and records of the Company and its
subsidiaries provided by the Shareholder, the Company or any of their respective
subsidiaries or representatives to the Purchaser or any representatives of the
Purchaser in connection with the transactions contemplated by this Agreement.

K. Meaning of "Knowledge". For the purposes of this Agreement
----------------------
"knowledge" of a party means the actual knowledge of current executive officers
of that party, as such knowledge has been obtained in the normal conduct of the
business of such party.

L. Successors and Assigns. This Agreement shall be binding upon and
----------------------
inure to the benefit of the successors and permitted assigns of the Shareholder,
the Company and the Purchaser, respectively. The Purchaser may assign its
rights under this Agreement to any corporation or other entity wholly owned by
it, but no such assignment shall
<PAGE>

constitute or be deemed to effect a release of the Purchaser from any
obligations or liabilities under this Agreement.

M. Governing Law. This Agreement shall be governed by and construed
-------------
in accordance with the laws of the State of New York, without regard to any
conflict of laws principles which would apply the laws of any other
jurisdiction.

N. Counterparts. This Agreement may be executed in counterparts,
------------
each of which shall be deemed an original, but all of which taken together shall
constitute one and the same instrument.

O. Headings. The headings in this Agreement are for convenience of
--------
reference only, and shall not be deemed to alter the meaning or interpretation
of any of the terms hereof.

* * *
<PAGE>

IN WITNESS WHEREOF, this Agreement has been duly executed by the parties
hereto as of the date first above written.

APEX HEALTHCARE, INC.

By /s/ Warwick Syphers
----------------------------
Warwick Syphers
Chief Financial Officer
and Executive Vice
President

RAMSAY MANAGED CARE, INC.

By /s/ Warwick Syphers
----------------------------
Warwick Syphers
Chief Financial Officer
and Executive Vice
President

ROTECH MEDICAL CORPORATION

By /s/ Stephen R. Griggs
-----------------------------
Stephen R. Griggs
President

<PAGE>

Exhibit 11

COMPUTATION OF NET INCOME (LOSS) PER SHARE
(UNAUDITED)
<TABLE>
<CAPTION>

QUARTER ENDED SEPTEMBER 30
1996 1995
------------- -------------
<S> <C> <C>
PRIMARY
Weighted average common shares outstanding...... 6,397,304 6,370,909
---------- ----------

TOTAL COMMON AND DILUTIVE
COMMON EQUIVALENT SHARES................... 6,397,304 6,370,909
========== ==========

Loss From Continuing Operations Available
to Common Shareholders............... $ (592,000) $ (834,000)
========== ==========

NET INCOME (LOSS) PER SHARE................ $ (0.09) $ (0.13)
========== ==========

FULLY DILUTED
Weighted average common shares outstanding...... 6,397,304 6,370,909
---------- ----------

TOTAL COMMON AND DILUTIVE
COMMON EQUIVALENT SHARES................... 6,397,304 6,370,909
========== ==========

Loss From Continuing Operations Available
to Common Shareholders............... $ (592,000) $ (834,000)
========== ==========

NET INCOME (LOSS) PER SHARE................ $ (0.09) $ (0.13)
========== ==========

</TABLE>

<PAGE>

<ARTICLE> 5

<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-1997
<PERIOD-START> JUL-01-1996
<PERIOD-END> SEP-30-1996
<CASH> 156,000
<SECURITIES> 0
<RECEIVABLES> 1,459,000
<ALLOWANCES> 291,000
<INVENTORY> 0
<CURRENT-ASSETS> 2,756,000
<PP&E> 2,008,000
<DEPRECIATION> 1,234,000
<TOTAL-ASSETS> 13,904,000
<CURRENT-LIABILITIES> 11,098,000
<BONDS> 0
0
3,000,000
<COMMON> 64,000
<OTHER-SE> (8,503,000)
<TOTAL-LIABILITY-AND-EQUITY> 14,904,000
<SALES> 0
<TOTAL-REVENUES> 5,822,000
<CGS> 0
<TOTAL-COSTS> 4,612,000
<OTHER-EXPENSES> 1,564,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 238,000
<INCOME-PRETAX> (592,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (592,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (592,000)
<EPS-PRIMARY> $(0.09)
<EPS-DILUTED> $(0.09)

</TABLE>